Annual Report • Jan 20, 2023
Annual Report
Open in ViewerOpens in native device viewer
January-December 2022
"Much of what defined 2022 will undoubtedly also define 2023. While uncertainty is high, Investor and our companies are well prepared to handle the challenges and capture the opportunities that lie ahead. Regardless of market environment, our companies benefit from being industry leaders with good profitability and exposure to secular growth areas."
Johan Forssell, President & CEO of Investor
| 12/31 2022 | 9/30 2022 | 12/31 2021 | |||
|---|---|---|---|---|---|
| Adjusted NAV, SEK m* | 673,250 | 626,292 | 760,962 | ||
| Adjusted NAV, SEK per share* | 220 | 204 | 248 | ||
| Reported NAV, SEK m*1) | 604,865 | 554,683 | 682,614 | ||
| Reported NAV, SEK per share*1) | 197 | 181 | 223 | ||
| Market capitalization (both share classes), excluding repurchased shares, SEK m | 584,163 | 510,961 | 711,230 | ||
| Share price (B-share), SEK | 188.56 | 163.58 | 227.75 | ||
| Q4 2022 | 2022 | ||||
| Adjusted NAV, sequential change, incl. dividend added back, SEK m* | 46,958 | -75,458 | |||
| Adjusted NAV, sequential change, incl. dividend added back, %* | 7 | -10 | |||
| Reported NAV, sequential change, incl. dividend added back, SEK m*1) | 50,182 | -65,495 | |||
| Reported NAV, sequential change, incl. dividend added back, %*1) | 9 | -10 | |||
| Market capitalization, sequential change, incl. dividend added back, SEK m* | 76,265 | -114,813 | |||
| Market capitalization, sequential change, incl. dividend added back, %* | 12 | -16 | |||
| Q4 2022 | Q4 2021 | 2022 | 2021 | ||
| Consolidated net sales, SEK m | 14,168 | 11,037 | 51,812 | 40,737 | |
| Consolidated profit/loss, SEK m | 51,567 | 81,091 | -74,762 | 227,965 | |
| Basic earnings per share, SEK | 16.82 | 26.47 | -24.38 | 74.45 | |
| * Financial measures that are not defined or specified in the applicable financial reporting framework. For more information, see page 18 and 30-31. Change in market capitalization |
with dividend added back reflects the change in total market capitalization with the dividend paid out added back. Change in net asset value with dividend added back includes the full dividend approved by the AGM.
1) In the reported net asset value, the wholly-owned subsidiaries and partner-owned investments within Patricia Industries are reported according to the acquisition and equity method respectively. Methods are further described in Investor AB's Annual Report.
| 1 year | 5 years | 10 years | 20 years | |
|---|---|---|---|---|
| Adjusted NAV incl. dividend added back, % | -9.9 | 14.0 | ||
| Investor B, total return, % | -15.4 | 17.8 | 19.3 | 17.9 |
| SIXRX return index, % | -22.8 | 9.8 | 12.1 | 12.3 |

Dear fellow shareholders,
During the fourth quarter, our adjusted net asset value grew by 7 percent and our total shareholder return amounted to 16 percent, compared to 11 percent for the SIXRX return index.
2022 was certainly challenging for the global economy, defined by sharply rising inflation and interest rates, soaring energy prices,
continued disruptions in global supply chains, and the lingering pandemic, but most of all by the terrible Russian invasion of Ukraine. Against this background, Investor and our portfolio showed strong resilience, with adjusted net asset value outperforming the Swedish stock market. Adjusted net asset value growth and total shareholder return amounted to -10 and -15 percent respectively, compared to -23 percent for the SIXRX. In an increasingly complex and fast-changing environment, Investor and our portfolio companies took important initiatives to futureproof our businesses:
Listed Companies' total return was -5 percent during 2022, compared to -23 percent for the SIXRX. The outperformance was driven by strong absolute returns in Saab and our healthcare holdings, as well as significant outperformance by large holdings such as ABB, SEB and Nasdaq.
During the year, our companies proceeded with strategic initiatives. For example, ABB divested the remaining part of the power grids business and spun off Accelleron to its shareholders. Husqvarna continued its shift from petroldriven to electrified products. Atlas Copco made several acquisitions to further strengthen its position in key areas, and AstraZeneca made successful progress within its oncology franchise. Ericsson continued to strengthen its compliance culture and, in early 2023, announced actions to improve profitability within Cloud Software and Services.
At the end of the year, Epiroc announced the acquisition of the Australian company CR Mining, expanding its offering of innovative consumables and digital solutions.
During the fourth quarter, based on estimated market values, Patricia Industries' total return was -4 percent, driven by lower multiples and negative currency impact, mitigated by higher earnings. The full year total return was -2 percent.
For the full year, sales growth for the major subsidiaries amounted to 28 percent, of which 9 percent organic in constant currency. Adjusted EBITA grew by 20 percent.
During the fourth quarter, organic sales grew 11 percent in constant currency, while adjusted EBITA grew 34 percent.
A key highlight was Permobil, reporting strong organic growth and a doubling of the operating profit. BraunAbility, Laborie and Sarnova all reported good underlying growth and margin expansion. Advanced Instruments had a tougher quarter, while Piab's reported margin was affected by costs relating to strategic projects.
During the quarter, Mölnlycke grew 9 percent organically in constant currency, mainly driven by Wound Care and Gloves, while profitability declined. The low margin in the quarter was negatively impacted by a reorganization of the Customer Care structure, and disturbances in the US Wound Care manufacturing plant due to staff shortages and supply issues, causing extra costs. Furthermore, capacity utilization in the new Gloves factory in Malaysia was low during ramp-up. The utilization rate is expected to gradually improve and management is making all efforts to normalize the US manufacturing situation.
In the quarter, the reported value of Investments in EQT increased by 2 percent and net cash flow to Investor amounted to SEK 1.4bn. During 2022, the value decreased by 35 percent, driven by EQT AB, while net cash flow to Investor amounted to a record SEK 6.2bn.
Our financial position strengthened further during the quarter, mainly driven by a EUR 300m distribution from Mölnlycke, the strong cash flow from EQT and proceeds from the divestiture of passive infrastructure in Three Scandinavia. At year-end, leverage amounted to 1.5 percent. With substantial gross cash, no debt maturities until 2029, and an underlying strong cash flow generation, our financial flexibility is high. Against this background, Investor's board of directors proposes a SEK 4.40 per share dividend for fiscal year 2022, an increase of 10 percent compared to last year.
The world is getting increasingly complex. Technology is advancing at great speed, the climate challenge needs to be handled urgently, and the geopolitical situation has deteriorated significantly. In addition, there are a number of political initiatives such as the Green Deal and the Inflation Reduction Act, that have substantial impact on many companies. As an engaged owner, we support our companies in trying to understand the implications of these over-arching complexities and how to position themselves in order to future-proof their businesses.
Much of what defined 2022 will undoubtedly also define 2023. While uncertainty is high, Investor and our companies are well prepared to handle the challenges and capture the opportunities that lie ahead. Regardless of market environment, our companies benefit from being industry leaders with good profitability and exposure to secular growth areas.
Our business model of building high-quality, industryleading companies through engaged ownership is well proven. Combined with our financial strength and all the dedicated people at Investor and in our companies, I am confident in our ability to continue to generate long-term attractive total returns to you, dear fellow shareholders.
Johan Forssell President & CEO
INVESTOR Q4 2022 – 3
| Adjusted values | Reported values | ||||||
|---|---|---|---|---|---|---|---|
| Number of | Ownership | Share of total | Value, | Value, | Value, | Value, | |
| shares 12/31 2022 |
capital/votes (%) 12/31 2022 |
assets (%) 12/31 2022 |
SEK m 12/31 2022 |
SEK m 12/31 2021 |
SEK m 12/31 2022 |
SEK m 12/31 2021 |
|
| Listed Companies | |||||||
| Atlas Copco | 836,131,135 | 17.0/22.3 | 15 | 102,091 | 128,968 | 102,091 | 128,968 |
| ABB | 265,385,142 | 13.5/13.5 | 12 | 83,944 | 91,732 | 83,944 | 91,732 |
| AstraZeneca | 51,587,810 | 3.3/3.3 | 11 | 72,403 | 54,807 | 72,403 | 54,807 |
| SEB | 456,198,927 | 20.9/21.0 | 8 | 54,646 | 57,458 | 54,646 | 57,458 |
| Epiroc | 207,757,845 | 17.1/22.7 | 6 | 39,075 | 47,298 | 39,075 | 47,298 |
| Nasdaq | 58,182,426 | 11.8/11.8 | 5 | 37,249 | 36,835 | 37,249 | 36,835 |
| Sobi | 107,594,165 | 34.7/34.7 | 3 | 23,270 | 19,957 | 23,270 | 19,957 |
| Saab | 40,972,622 | 30.2/39.7 | 2 | 16,852 | 9,440 | 16,852 | 9,440 |
| Ericsson | 266,745,735 | 8.0/23.8 | 2 | 16,849 | 26,589 | 16,849 | 26,589 |
| Wärtsilä | 104,711,363 | 17.7/17.7 | 1 | 9,196 | 13,242 | 9,196 | 13,242 |
| Electrolux | 50,786,412 | 17.9/30.4 | 1 | 7,151 | 11,089 | 7,151 | 11,089 |
| Husqvarna | 97,052,157 | 16.8/33.4 | 1 | 7,122 | 13,986 | 7,122 | 13,986 |
| Accelleron1) | 13,269,257 | 14.0/14.0 | 0 | 2,868 | - | 2,868 | - |
| Electrolux Professional | 58,941,654 | 20.5/32.4 | 0 | 2,579 | 3,677 | 2,579 | 3,677 |
| Total Listed Companies | 70 | 475,296 | 515,078 | 475,296 | 515,078 | ||
| Patricia Industries | Total exposure (%) | ||||||
| Subsidiaries | |||||||
| Mölnlycke2) | 99 | 9 | 58,888 | 72,926 | 18,780 | 17,787 | |
| Laborie | 98 | 2 | 15,991 | 14,727 | 9,580 | 8,276 | |
| Sarnova | 96 | 2 | 12,674 | 11,099 | 8,029 | 6,527 | |
| Permobil2) | 98 | 2 | 11,651 | 10,747 | 5,211 | 4,363 | |
| Advanced Instruments | 98 | 1 | 10,073 | 6,952 | 8,575 | 7,082 | |
| Piab2) | 96 | 1 | 7,869 | 8,029 | 6,189 | 5,702 | |
| BraunAbility | 93 | 1 | 5,222 | 3,641 | 2,388 | 2,365 | |
| Vectura | 99 | 1 | 3,845 | 3,630 | 3,821 | 3,705 | |
| Atlas Antibodies | 93 | 0 | 2,807 | 2,960 | 2,853 | 2,313 | |
| Total subsidiaries | 19 | 129,019 | 134,710 | 65,424 | 58,120 | ||
| Three Scandinavia | 40/40 | 1 | 7,504 | 6,801 | 2,7143) | 5,043 | |
| Financial Investments | 0 | 1,972 | 2,594 | 1,972 | 2,594 | ||
| Total Patricia Industries excl. cash | 20 | 138,495 | 144,106 | 70,110 | 65,758 | ||
| Total Patricia Industries incl. cash | 150,317 | 156,611 | 81,933 | 78,263 | |||
| Investments in EQT | |||||||
| EQT AB | 174,288,016 | 14.6/14.7 | 6 | 38,500 | 85,872 | 38,500 | 85,872 |
| Fund investments | 5 | 31,550 | 30,768 | 31,550 | 30,768 | ||
| Total Investments in EQT | 10 | 70,050 | 116,640 | 70,050 | 116,640 | ||
| Other Assets and Liabilities | 0 | -328 | -371 | -328 | -371 | ||
| Total Assets excl. cash Patricia Industries | 100 | 683,513 | 775,453 | 615,128 | 697,105 | ||
| Gross debt* | -38,796 | -38,446 | -38,796 | -38,446 | |||
| Gross cash* | 28,533 | 23,955 | 28,533 | 23,955 | |||
| Of which Patricia Industries | 11,823 | 12,505 | 11,823 | 12,505 | |||
| Net debt | -10,263 | -14,491 | -10,263 | -14,491 | |||
| Net Asset Value | 673,250 | 760,962 | 604,865 | 682,614 | |||
| Net Asset Value per share | 220 | 248 | 197 | 223 |
1) On September 7, 2022 an Extraordinary General Meeting in ABB decided to spin-off Accelleron from ABB and distribute the Accelleron shares to the shareholders of ABB as a dividend in kind. The first day of trading in Accelleron was October 3, 2022. SEK 2,683m has been transferred from the value of ABB to the value of Accelleron on the date of the distribution.
2) Including receivables related to Management Participation Program foundations. For Mölnlycke, the receivable corresponds to less than 1 percentage point of the total exposure, for Permobil to approximately 2 percentage points and for Piab to approximately 4 percentage points.
3) Negatively impacted by a write-down on network assets following a change in useful life.
For balance sheet items, figures in parentheses refer to year-end 2021 figures. For income statement and cash flow items, they refer to the same period last year.
During 2022, adjusted net asset value decreased from SEK 761.0bn to SEK 673.2bn. The change in adjusted net asset value, with dividend added back, was -10 percent during the period (41), of which 7 percent during the fourth quarter (12).
Reported net asset value decreased from SEK 682.6bn to SEK 604.9bn. The change in reported net asset value, with dividend added back, was -10 percent during the period (50), of which 9 percent during the fourth quarter (14).
Total adjusted assets by business area

Net debt totaled SEK 10,263m on December 31, 2022 (14,491), corresponding to leverage of 1.5 percent (1.9).
Our target leverage range is 0-10 percent (net debt/total adjusted assets) over a business cycle. While leverage can fluctuate above and below the target level, it should not exceed 20 percent for a longer period of time.
Gross cash amounted to SEK 28,533m and gross debt to SEK 38,796m as of December 31, 2022. The average maturity of Investor AB's debt portfolio was 11.8 years on December 31, 2022 (10.8).

| SEK m | 2022 |
|---|---|
| Opening net debt | -14,491 |
| Listed Companies | |
| Dividends | 10,935 |
| Other capital distributions | 1,662 |
| Investments, net of proceeds | -517 |
| Management cost | -148 |
| Total | 11,932 |
| Patricia Industries | |
| Proceeds | 4,807 |
| Investments | -2,205 |
| Internal transfer to Investor | -3,124 |
| Management cost | -336 |
| Other1) | 174 |
| Total | -683 |
| Investments in EQT | |
| Proceeds (divestitures, fee surplus and carry) | 10,220 |
| Drawdowns (investments and management fees) | -3,989 |
| Management cost | -11 |
| Total | 6,220 |
| Investor groupwide | |
| Dividend to shareholders | -12,254 |
| Internal transfer from Patricia Industries | 3,124 |
| Management cost | -130 |
| Other2) | -3,981 |
| Closing net debt | -10,263 |
| 1) Incl. currency related effects and net interest paid. |
2) Incl. currency related effects, revaluation of debt and net interest paid.
Investor's management cost amounted to SEK 188m during the fourth quarter 2022 (158).
As of December 31, 2022, rolling 12-month management cost amounted to 0.09 percent of the adjusted net asset value.
The price of the Investor A-share and B-share was SEK 193.85 and SEK 188.56 respectively on December 31, 2022, compared to SEK 238.60 and SEK 227.75 on December 31, 2021.
The total shareholder return (Class B-share) amounted to -15 percent during 2022 (55), of which 16 percent during the fourth quarter (21).
The SIXRX return index was -23 percent during 2022 (39), of which 11 percent during the fourth quarter (12).
Investor's market capitalization, excluding repurchased shares, was SEK 584,163m as of December 31, 2022 (711,230).

Listed Companies include ABB, Accelleron, AstraZeneca, Atlas Copco, Electrolux, Electrolux Professional, Epiroc, Ericsson, Husqvarna, Nasdaq, Saab, SEB, Sobi and Wärtsilä. These are multinational companies with strong market positions and proven track records. In general, they are well positioned and we work continuously to support them to remain or become best-in-class.
• Listed Companies generated a total return of 12 percent, mainly driven by strong performance in our largest holdings.
Total return (excluding management costs) amounted to -5 percent during 2022, of which 12 percent during the fourth quarter.
The SIXRX return index was -23 percent during 2022, of which 11 percent during the fourth quarter.

Contribution to net asset value (adjusted and reported) amounted to SEK -27,851m during 2022 (159,327), of which SEK 52,267m during the fourth quarter (53,320).
| SEK m | Q4 2022 | 2022 | 2021 |
|---|---|---|---|
| Changes in value | 50,895 | -38,638 | 148,616 |
| Dividends | 1,416 | 10,935 | 10,834 |
| Management cost | -45 | -148 | -123 |
| Total | 52,267 | -27,851 | 159,327 |
| Q4 2022 | 2022 | |||||
|---|---|---|---|---|---|---|
| Value, SEK m |
Contribution, SEK m |
Total return (%)1) |
Contribution, SEK m |
Total return (%) |
||
| Atlas Copco | 102,091 | 15,741 | 18.2 | -24,132 | -18.6 | |
| ABB | 83,944 | 6,192 | 11.4 | -5,583 | -3.1 | |
| AstraZeneca | 72,403 | 8,667 | 13.6 | 19,015 | 35.2 | |
| SEB | 54,646 | 5,725 | 11.7 | -88 | 0.7 | |
| Epiroc | 39,075 | 6,329 | 19.3 | -7,600 | -16.0 | |
| Nasdaq | 37,249 | 684 | 1.8 | 852 | 2.4 | |
| Sobi | 23,270 | 86 | 0.4 | 3,313 | 16.6 | |
| Saab | 16,852 | 2,647 | 18.6 | 7,613 | 81.1 | |
| Ericsson | 16,849 | -783 | -4.4 | -9,073 | -34.5 | |
| Wärtsilä | 9,196 | 1,706 | 22.8 | -3,773 | -28.4 | |
| Electrolux | 7,151 | 1,255 | 21.3 | -3,471 | -30.9 | |
| Husqvarna | 7,122 | 1,280 | 21.9 | -6,576 | -46.9 | |
| Accelleron | 2,868 | 2,868 | 6.9 | 2,868 | 6.9 | |
| Electrolux Professional |
2,579 | -86 | -3.2 | -1,069 | -29.2 | |
| Total | 475,296 | 52,311 | 12.4 | -27,703 | -5.2 |
1) Calculated as the sum of share price changes with reinvested dividends, including add-on investments and/or divestments.
Dividends received totaled SEK 10,935m during 2022 (10,834), of which SEK 1,416m during the fourth quarter (3,134). In addition, 13,269,257 shares in Accelleron Industries AG were received as a dividend in kind during the fourth quarter 2022.
Redemptions received totaled SEK 1,662m during 2022, of which SEK 1,662m during the second quarter, relating to the mandatory redemption program in Atlas Copco.

During 2022, investments amounted to SEK 501m, of which SEK 0m during the fourth quarter. The investments relate to the purchase of 5,114,571 B-shares in Atlas Copco during the third quarter.
Divestments amounted to SEK 1,662m, of which SEK 1,662m during the second quarter, relating to the divestment of 207,754,141 redemption rights in Atlas Copco's mandatory redemption program.

Patricia Industries develops wholly-owned companies in the Nordics and in North America. Holdings include Advanced Instruments, Atlas Antibodies, BraunAbility, Laborie, Mölnlycke, Permobil, Piab, Sarnova, Vectura, Three Scandinavia and Financial Investments.
During 2022, sales growth for the major subsidiaries was 28 percent. Organic growth was 9 percent in constant currency. EBITA amounted to SEK 9,217m, an increase of 21 percent. Adjusting for items affecting comparability, mainly related to transaction and integration costs, EBITA grew by 20 percent.
During the fourth quarter 2022, sales growth amounted to 32 percent. Organic growth was 11 percent in constant currency. EBITA amounted to SEK 2,442m, an increase of 39 percent. Adjusted EBITA grew by 34 percent.
During 2022, the companies' (subsidiaries and 40 percent of Three Scandinavia) combined sales amounted to SEK 54.3bn, while EBITDA amounted to SEK 12.3bn. The corresponding figures for the fourth quarter were SEK 14.9bn and SEK 3.3bn respectively.

Reported EBITDA (subsidiaries & 40% of Three Scandinavia)

| Org. growth, constant |
Operating | ||||||
|---|---|---|---|---|---|---|---|
| SEK m | Sales | currency | EBITDA | EBITDA (%) | EBITA1) | EBITA, (%) | cash flow |
| Mölnlycke | 5,179 | 9 | 1,158 | 22.2 | 974 | 18.7 | 849 |
| Laborie | 949 | 9 | 308 | 32.7 | 288 | 30.6 | 148 |
| Sarnova | 2,621 | 6 | 437 | 16.8 | 389 | 15.0 | 307 |
| Permobil | 1,545 | 17 | 389 | 25.1 | 335 | 21.7 | 252 |
| Advanced Instruments | 376 | -5 | 121 | 32.1 | 115 | 30.6 | 72 |
| Piab | 661 | 7 | 122 | 18.4 | 97 | 14.7 | 113 |
| BraunAbility | 2,589 | 25 | 254 | 9.9 | 198 | 7.7 | 149 |
| Vectura | 78 | 9 | 42 | 53.9 | 10 | 12.5 | -160 |
| Atlas Antibodies | 98 | 9 | 42 | 42.8 | 36 | 37.0 | 17 |
| Total | 14,098 | 2,872 | 20.4 | 2,442 | 17.3 | 1,747 | |
| Reported growth y/y, % | 32 | 34 | 39 | ||||
| Organic growth, y/y, % | 11 |
2022
| Org. growth, constant |
Operating | ||||||
|---|---|---|---|---|---|---|---|
| SEK m | Sales | currency | EBITDA | EBITDA (%) | EBITA1) | EBITA, (%) | cash flow |
| Mölnlycke | 19,432 | 4 | 5,064 | 26.1 | 4,362 | 22.4 | 3,171 |
| Laborie | 3,434 | 12 | 983 | 28.6 | 915 | 26.7 | 495 |
| Sarnova | 9,283 | 2 | 1,370 | 14.8 | 1,198 | 12.9 | 1,034 |
| Permobil | 5,248 | 9 | 1,071 | 20.4 | 880 | 16.8 | 435 |
| Advanced Instruments | 1,359 | 7 | 457 | 33.6 | 436 | 32.1 | 359 |
| Piab | 2,450 | 11 | 619 | 25.2 | 530 | 21.6 | 411 |
| BraunAbility | 9,402 | 28 | 874 | 9.3 | 680 | 7.2 | 465 |
| Vectura | 302 | 28 | 178 | 58.9 | 50 | 16.7 | -614 |
| Atlas Antibodies | 398 | 14 | 187 | 47.0 | 165 | 41.4 | 94 |
| Total | 51,309 | 10,802 | 21.1 | 9,217 | 18.0 | 5,850 | |
| Reported growth y/y, % | 28 | 20 | 21 | ||||
| Organic growth, y/y, % | 9 |
1) EBITA is defined as operating profit before acquisition-related amortizations.
Contribution to adjusted net asset value amounted to SEK -3,321m during 2022 (3,694), of which SEK -5,857m during the fourth quarter (-2,063).
Contribution to adjusted net asset value
| SEK m | Q4 2022 | 2022 | 2021 |
|---|---|---|---|
| Changes in value | -5,777 | -3,009 | 3,933 |
| Management cost | -96 | -336 | -261 |
| Other | 16 | 23 | 21 |
| Total | -5,857 | -3,321 | 3,694 |
Based on estimated market values, the total return for Patricia Industries, excluding cash, amounted to -2 percent (-2 percent including cash) during 2022, of which -4 percent during the fourth quarter (-4 percent including cash). The negative return during the fourth quarter was driven by lower multiples and negative currency effects, partly offset by higher earnings.
For more information on valuation, see page 35.
During 2022, investments amounted to SEK 2,204m, of which SEK 9m during the fourth quarter. Investments mainly relate to equity investments in Advanced Instruments, Piab, Laborie and Permobil earlier during the year.
Divestments amounted to SEK 373m, of which SEK 69m during the fourth quarter. Within Financial Investments, 24Health divested the Doktor24 business during the fourth quarter.
During 2022, distributions to Patricia Industries amounted to SEK 4,434m, of which SEK 4,343m during the fourth quarter. Out of these, SEK 3,247m relates to Mölnlycke. Regarding the distribution from Three Scandinavia related to the divestment of its passive network infrastructure, approximately SEK 3.2bn has previously been received and approximately SEK 1.1bn in cash and SEK 0.6bn worth of Cellnex shares was received during the fourth quarter. In total, SEK 4.9bn has been received from the divestment.
Distribution to Patricia Industries

| Patricia Industries, net cash | ||||
|---|---|---|---|---|
| SEK m | Q4 2022 | 2022 | 2021 | |
| Beginning of period | 7,495 | 12,505 | 13,468 | |
| Net cash flow | 4,404 | 2,602 | 2,125 | |
| Internal transfer to Investor | - | -3,124 | -2,938 | |
| Other1) | -76 | -161 | -150 | |
| End of period | 11,823 | 11,823 | 12,505 | |
| 1) Includes currency-related effects, net interest and management cost. |
|---|
| Patricia Industries – valuation overview | ||||
|---|---|---|---|---|
| Estimated market values, SEK m, 12/31, 2022 |
Change Q4 2022 vs. Q3 2022 SEK m |
Major drivers | Comments | |
| Subsidiaries | ||||
| Mölnlycke | 58,888 | -8,523 | Lower multiples impacted negatively, SEK 3.2bn distribution to Patricia Industries |
Applied EV/reported LTM EBITDA 14.6x |
| Laborie | 15,991 | -1,288 | Lower multiples and currency impacted negatively, mitigated by higher earnings |
Applied EV/adj. LTM EBITDA 17.5x |
| Sarnova | 12,674 | 234 | Higher earnings impacted positively, currency impacted negatively |
Implied EV/reported LTM EBITDA 13.3x. Acquisition of Allied 100 valued at cost |
| Permobil | 11,651 | 2,570 | Higher earnings impacted positively, lower multiples impacted negatively |
Applied EV/adj. LTM EBITDA 14.2x |
| Advanced Instruments | 10,073 | -1,559 | Lower multiples and currency impacted negatively |
Applied EV/adj. LTM EBITDA 17.9x. Acquisitions of Solentim and Artel valued at cost |
| Piab | 7,869 | 237 | No major drivers | Applied EV/adj. LTM EBITDA 15.5x |
| BraunAbility | 5,222 | 443 | Higher earnings impacted positively, lower multiples and currency impacted negatively. Acquisition of Q'Straint at estimated market value for the first time |
Implied EV/reported LTM EBITDA 9.5x |
| Vectura | 3,845 | 13 | No major drivers | Estimated market value of the property portfolio less debt and cost |
| Atlas Antibodies | 2,807 | -146 | No major drivers | Implied EV/reported LTM EBITDA 17.9x |
| Partner-owned investments |
||||
| Three Scandinavia | 7,504 | -1,574 | Lower multiples impacted negatively, SEK 1.1bn distribution of proceeds from divestment of passive network infrastructure |
Applied EV/LTM adj. EBITDA 6.7x. The estimated market value includes a discounted value of the Cellnex shares received |
| Financial Investments | 1,972 | -590 | Multiple or third-party valuation, share price | |
| Total | 138,495 | |||
| Total incl. cash | 150,317 |

A provider of single-use products and solutions for managing wounds, improving surgical safety and efficiency, and preventing pressure ulcers. Read more at www.molnlycke.com
• Organic sales growth amounted to 23 percent in constant currency, with strong underlying demand in both the US and EMEA, while the comparison period from 2021 was negatively impacted by covid-related production shutdowns.
• Organic sales growth amounted to 5 percent in constant currency, with an improved product supply situation in the US.

| Income statement items, | 2022 | 2021 | ||
|---|---|---|---|---|
| EUR m | Q4 | YTD | Q4 | YTD |
| Sales | 474 | 1,828 | 420 | 1,686 |
| EBITDA | 105 | 476 | 106 | 485 |
| EBITA | 89 | 410 | 89 | 421 |
| Sales growth, % | 13 | 8 | -24 | -6 |
| Organic growth, constant currency, % |
9 | 4 | -26 | -6 |
| EBITDA, % | 22.2 | 26.1 | 25.1 | 28.8 |
| EBITA, % | 18.7 | 22.4 | 21.2 | 25.0 |
| Cash flow items, EUR m | Q4 | YTD | Q4 | YTD |
| EBITDA | 105 | 476 | 106 | 485 |
| Lease payments | -7 | -22 | -5 | -21 |
| Change in working capital | 0 | -86 | 44 | -34 |
| Capital expenditures | -21 | -70 | -17 | -49 |
| Operating cash flow | 78 | 298 | 128 | 382 |
| Acquisitions/divestments | - | -1 | - | - |
| Shareholder contribution/distribution | -300 | -300 | -50 | -250 |
| Other1) | 20 | -108 | -19 | -150 |
| Increase(-)/decrease(+) in net debt | -202 | -111 | 58 | -18 |
| Key ratios | ||||
| Working capital/sales, % | 18 | |||
| Capital expenditures/sales, % | 4 | |||
| Balance sheet items, EUR m | 12/31 2022 | 12/31 2021 | ||
| Net debt | 1,621 | 1,510 | ||
| 12/31 2022 | 12/31 2021 | |||
| Number of employees | 8,775 | 8,315 |
1) Includes effects of exchange rate changes, interest, tax and change in lease liabilities.
| Share of sales, (%) Last 12 months |
Organic growth, constant currency, (%) Q4 2022 |
|
|---|---|---|
| Wound Care | 58 | 9 |
| Operating Room Solutions |
25 | 4 |
| Gloves | 14 | 23 |
| Antiseptics | 3 | 5 |
| Total | 100 | 9 |
| Share of sales, (%) 2022 |
|
|---|---|
| Europe, Middle East, Africa | 56 |
| Americas | 35 |
| Asia Pacific | 9 |
| Total | 100 |
A provider of diagnostic and therapeutic products within Gastroenterology, Urology & Urogynecology, and Obstetrics, Gynecology & Neonatal. Read more at www.laborie.com
| Income statement items, | 2022 | 2021 | ||
|---|---|---|---|---|
| USD m | Q4 | YTD | Q4 | YTD |
| Sales | 89 | 339 | 84 | 313 |
| EBITDA | 29 | 97 | 22 | 93 |
| EBITA | 27 | 90 | 20 | 83 |
| Sales growth, % | 6 | 8 | 20 | 36 |
| Organic growth, constant currency, % |
9 | 12 | 14 | 21 |
| EBITDA, % | 32.7 | 28.6 | 26.4 | 29.9 |
| EBITA, % | 30.6 | 26.7 | 24.2 | 26.6 |
| Cash flow items, USD m | Q4 | YTD | Q4 | YTD |
| EBITDA | 29 | 97 | 22 | 93 |
| Lease payments | 0 | -2 | -1 | -4 |
| Change in working capital | -13 | -39 | 0 | -20 |
| Capital expenditures | -2 | -7 | -1 | -10 |
| Operating cash flow | 14 | 49 | 20 | 60 |
| Acquisitions/divestments | - | -167 | -74 | -74 |
| Shareholder contribution/distribution | - | 100 | - | - |
| Other1) | -8 | -11 | -4 | -8 |
| Increase(-)/decrease(+) in net debt | 6 | -30 | -58 | -22 |
| Key ratios | ||||
| Working capital/sales, % | 20 | |||
| Capital expenditures/sales, % | 2 | |||
| Balance sheet items, USD m | 12/31 2022 | 12/31 2021 | ||
| Net debt | 454 | 424 | ||
| 12/31 2022 | 12/31 2021 | |||
| Number of employees | 895 | 780 |
1) Includes effects of exchange rate changes, interest, tax and change in lease liabilities.

A US provider of specialty healthcare and safety products, services and software for the US emergency medical services (EMS), acute care and cardiac response markets. Read more at www.sarnova.com
| Income statement items, | 2022 | 2021 | ||
|---|---|---|---|---|
| USD m | Q4 | YTD | Q4 | YTD |
| Sales | 245 | 917 | 233 | 835 |
| EBITDA | 41 | 135 | 30 | 104 |
| EBITA | 37 | 118 | 25 | 91 |
| Sales growth, % | 6 | 10 | 17 | 15 |
| Organic growth, constant currency, % |
6 | 2 | 0 | 0 |
| EBITDA, % | 16.8 | 14.8 | 13.1 | 12.5 |
| EBITA, % | 15.0 | 12.9 | 10.9 | 10.9 |
| Cash flow items, USD m | Q4 | YTD | Q4 | YTD |
| EBITDA | 41 | 135 | 30 | 104 |
| Lease payments | -1 | -4 | -1 | -4 |
| Change in working capital | -9 | -11 | 3 | 6 |
| Capital expenditures | -2 | -18 | -11 | -29 |
| Operating cash flow | 29 | 102 | 21 | 77 |
| Acquisitions/divestments | - | - | - | -289 |
| Shareholder contribution/distribution | - | - | - | 210 |
| Other1) | -14 | -60 | -12 | -41 |
| Increase(-)/decrease(+) in net debt | 15 | 43 | 9 | -44 |
| Key ratios | ||||
| Working capital/sales, % | 14 | |||
| Capital expenditures/sales, % | 2 | |||
| Balance sheet items, USD m | 12/31 2022 | 12/31 2021 | ||
| Net debt | 526 | 569 | ||
| 12/31 2022 | 12/31 2021 | |||
| Number of employees | 1,435 | 1,370 |
A provider of advanced mobility and seating rehab solutions, including powered and manual wheelchairs, pressure-relieving cushions and powerassist devices. Read more at www.permobil.com
| Income statement items, | 2022 | 2021 | ||
|---|---|---|---|---|
| SEK m | Q4 | YTD | Q4 | YTD |
| Sales | 1,545 | 5,248 | 1,119 | 4,062 |
| EBITDA | 389 | 1,071 | 192 | 782 |
| EBITA | 335 | 880 | 149 | 612 |
| Sales growth, % | 38 | 29 | 10 | 3 |
| Organic growth, constant currency, % |
17 | 9 | 6 | 6 |
| EBITDA, % | 25.1 | 20.4 | 17.2 | 19.2 |
| EBITA, % | 21.7 | 16.8 | 13.3 | 15.1 |
| Cash flow items, SEK m | Q4 | YTD | Q4 | YTD |
| EBITDA | 389 | 1,071 | 192 | 782 |
| Lease payments | -16 | -68 | -19 | -62 |
| Change in working capital | -48 | -295 | -91 | -330 |
| Capital expenditures | -73 | -273 | -45 | -175 |
| Operating cash flow | 252 | 435 | 37 | 214 |
| Acquisitions/divestments | - | -280 | - | -262 |
| Shareholder contribution/distribution | - | 350 | - | - |
| Other1) | 170 | -668 | -178 | -559 |
| Increase(-)/decrease(+) in net debt | 422 | -164 | -140 | -607 |
| Key ratios | ||||
| Working capital/sales, % | 26 | |||
| Capital expenditures/sales, % | 5 | |||
| Balance sheet items, SEK m | 12/31 2022 | 12/31 2021 | ||
| Net debt | 3,330 | 3,166 | ||
| 12/31 2022 | 12/31 2021 | |||
| Number of employees | 1,805 | 1,660 | ||
1) Includes effects of exchange rate changes, interest, tax and change in lease liabilities.

A provider of scientific and analytical instruments for the biotechnology, clinical and food & beverage industries. Read more at www.aicompanies.com
| Income statement items, | 2022 | 2021 | ||
|---|---|---|---|---|
| USD m | Q4 | YTD | Q4 | YTD |
| Sales | 35 | 134 | 31 | 103 |
| EBITDA | 11 | 45 | 12 | 38 |
| EBITA | 11 | 43 | 11 | 37 |
| Sales growth, % | 13 | 31 | 45 | 34 |
| Organic growth, constant currency, % |
-5 | 7 | 18 | 24 |
| EBITDA, % | 32.1 | 33.6 | 37.1 | 37.1 |
| EBITA, % | 30.6 | 32.1 | 35.8 | 35.7 |
| Cash flow items, USD m | Q4 | YTD | Q4 | YTD |
| EBITDA | 11 | 45 | 12 | 38 |
| Lease payments | 0 | -1 | 0 | -1 |
| Change in working capital | -4 | -7 | -1 | -3 |
| Capital expenditures | 0 | -1 | -1 | -2 |
| Operating cash flow | 7 | 35 | 10 | 32 |
| Acquisitions/divestments | - | -77 | - | -238 |
| Shareholder contribution/distribution | - | 50 | - | 170 |
| Other1) | -7 | -20 | -2 | -7 |
| Increase(-)/decrease(+) in net debt | 0 | -11 | 8 | -43 |
| Key ratios | ||||
| Working capital/sales, % | 12 | |||
| Capital expenditures/sales, % | 1 | |||
| Balance sheet items, USD m | 12/31 2022 | 12/31 2021 | ||
| Net debt | 206 | 195 | ||
| 12/31 2022 | 12/31 2021 | |||
| Number of employees | 370 | 225 |

A provider of gripping and moving solutions for end-users and machine manufacturers to improve energy efficiency, productivity and work environment. Read more at www.piab.com
| Income statement items, | 2022 | 2021 | ||
|---|---|---|---|---|
| SEK m | Q4 | YTD | Q4 | YTD |
| Sales | 661 | 2,450 | 472 | 1,738 |
| EBITDA | 122 | 619 | 109 | 485 |
| EBITA | 97 | 530 | 81 | 409 |
| Sales growth, % | 40 | 41 | 8 | 14 |
| Organic growth, | 7 | 11 | 8 | 18 |
| constant currency, % | ||||
| EBITDA, % | 18.4 | 25.2 | 23.1 | 27.9 |
| EBITA, % | 14.7 | 21.6 | 17.2 | 23.5 |
| Cash flow items, SEK m | Q4 | YTD | Q4 | YTD |
| EBITDA | 122 | 619 | 109 | 485 |
| Lease payments | -11 | -41 | -8 | -32 |
| Change in working capital | 26 | -95 | -9 | -42 |
| Capital expenditures | -24 | -72 | -13 | -35 |
| Operating cash flow | 113 | 411 | 79 | 376 |
| Acquisitions/divestments | - | -715 | -254 | -254 |
| Shareholder contribution/distribution | - | 210 | - | -60 |
| Other1) | 48 | -569 | -87 | -256 |
| Increase(-)/decrease(+) in net debt | 161 | -663 | -262 | -193 |
| Key ratios | ||||
| Working capital/sales, % | 18 | |||
| Capital expenditures/sales, % | 3 | |||
| Balance sheet items, SEK m | 12/31 2022 | 12/31 2021 | ||
| Net debt | 2,431 | 1,767 | ||
| 12/31 2022 | 12/31 2021 | |||
| Number of employees | 1,030 | 695 |
1) Includes effects of exchange rate changes, interest, tax and change in lease liabilities.

A provider of mobility transportation solutions, including wheelchair accessible vehicles, lifts and seating, storage and securement products. Read more at www.braunability.com
| Income statement items, | 2022 | 2021 | ||
|---|---|---|---|---|
| USD m | Q4 | YTD | Q4 | YTD |
| Sales | 242 | 929 | 184 | 692 |
| EBITDA | 24 | 86 | 13 | 52 |
| EBITA | 19 | 67 | 9 | 35 |
| Sales growth, % | 32 | 34 | 22 | 22 |
| Organic growth, constant currency, % |
25 | 28 | 14 | 17 |
| EBITDA, % | 9.9 | 9.3 | 7.2 | 7.5 |
| EBITA, % | 7.7 | 7.2 | 4.6 | 5.1 |
| Cash flow items, USD m | Q4 | YTD | Q4 | YTD |
| EBITDA | 24 | 86 | 13 | 52 |
| Lease payments | -2 | -7 | -2 | -9 |
| Change in working capital | -5 | -21 | 1 | 7 |
| Capital expenditures | -2 | -12 | -4 | -12 |
| Operating cash flow | 14 | 46 | 8 | 38 |
| Acquisitions/divestments | - | -8 | - | -76 |
| Shareholder contribution/distribution | - | - | - | 20 |
| Other1) | -10 | -22 | -1 | -94 |
| Increase(-)/decrease(+) in net debt | 4 | 16 | 7 | -111 |
| Key ratios | ||||
| Working capital/sales, % | 7 | |||
| Capital expenditures/sales, % | 1 | |||
| Balance sheet items, USD m | 12/31 2022 | 12/31 2021 | ||
| Net debt | 284 | 300 | ||
| 12/31 2022 | 12/31 2021 | |||
| Number of employees | 1,945 | 1,825 |
Develops and manages properties within community service and commercial with a long-term commitment. Read more at www.vectura.se
| Income statement items, | 2022 | 2021 | ||
|---|---|---|---|---|
| SEK m | Q4 | YTD | Q4 | YTD |
| Sales | 78 | 302 | 71 | 279 |
| EBITDA | 42 | 178 | 42 | 172 |
| EBITDA, % | 53.9 | 58.9 | 59.2 | 61.5 |
| EBITA adj.1) | 10 | 50 | 7 | 45 |
| EBITA adj % | 12.5 | 16.7 | 9.5 | 16.0 |
| Balance sheet items, SEK m | 12/31 2022 | 12/31 2021 | ||
| Net debt | 5,223 | 3,963 | ||
| 12/31 2022 | 12/31 2021 | |||
| Real estate market value | 9,650 | 8,388 | ||
| 12/31 2022 | 12/31 2021 | |||
| Number of employees | 49 | 33 |
1) EBITA adjusted for depreciation of surplus values related to properties.
A provider of advanced reagents for basic and clinical biomedical research. Read more at www.atlasantibodies.com
| Income statement items, | 2022 | 2021 | ||
|---|---|---|---|---|
| SEK m | Q4 | YTD | Q4 | YTD |
| Sales | 98 | 398 | 81 | 324 |
| EBITDA | 42 | 187 | 42 | 162 |
| EBITA | 36 | 165 | 37 | 143 |
| Sales growth, % | 21 | 23 | 23 | 31 |
| Organic growth, constant currency, % |
9 | 14 | 19 | 34 |
| EBITDA, % | 42.8 | 47.0 | 51.4 | 50.1 |
| EBITA, % | 37.0 | 41.4 | 45.0 | 44.2 |
| Cash flow items, SEK m | Q4 | YTD | Q4 | YTD |
| EBITDA | 42 | 187 | 42 | 162 |
| Lease payments | -2 | -8 | -2 | -6 |
| Change in working capital | -21 | -68 | -12 | -32 |
| Capital expenditures | -2 | -17 | -4 | -9 |
| Operating cash flow | 17 | 94 | 24 | 115 |
| Acquisitions/divestments | - | - | - | -2,629 |
| Shareholder contribution/distribution | - | - | - | 2,030 |
| Other1) | -7 | -30 | 0 | -39 |
| Increase(-)/decrease(+) in net debt | 10 | 64 | 23 | -522 |
| Key ratios | ||||
| Working capital/sales, % | 45 | |||
| Capital expenditures/sales, % | 4 | |||
| Balance sheet items, SEK m | 12/31 2022 | 12/31 2021 | ||
| Net debt | 342 | 406 | ||
| 12/31 2022 | 12/31 2021 | |||
| Number of employees | 130 | 115 |

Provides mobile voice and broadband services in Sweden and Denmark. Read more at www.tre.se.
| Key figures, Three Scandinavia | ||||
|---|---|---|---|---|
| 2022 | 2021 | |||
| Income statement items | Q4 | YTD | Q4 | YTD |
| Sales, SEK m | 3,283 11,834 | 2,925 10,750 | ||
| Sweden, SEK m | 2,160 | 7,668 | 1,929 | 6,946 |
| Denmark, DKK m | 756 | 2,904 | 730 | 2,787 |
| Service revenue, SEK m1) | 1,947 | 7,505 | 1,763 | 6,913 |
| Sweden, SEK m | 1,220 | 4,752 | 1,138 | 4,402 |
| Denmark, DKK m | 489 | 1,920 | 458 | 1,839 |
| EBITDA, SEK m | 973 | 3,729 | 931 | 3,535 |
| Sweden, SEK m | 706 | 2,732 | 636 | 2,564 |
| Denmark, DKK m | 180 | 694 | 216 | 711 |
| EBITDA, % | 29.7 | 31.5 | 31.8 | 32.9 |
| Sweden | 32.7 | 35.6 | 33.0 | 36.9 |
| Denmark | 23.8 | 23.9 | 29.6 | 25.5 |
| Key ratios | ||||
| Capital expenditures/sales, % | 22 | |||
| Balance sheet items, SEK m | 12/31 2022 | 12/31 2021 | ||
| Net debt | 7,294 | 6,498 | ||
| 12/31 2022 | 12/31 2021 | |||
| Number of employees | 1,790 | 1,735 | ||
| Other key figures | 12/31 2022 | 12/31 2021 | ||
| Subscriptions | 4,004,000 | 3,834,000 | ||
| Sweden | 2,464,000 | 2,337,000 | ||
| Denmark | 1,540,000 | 1,496,000 | ||
1) Mobile service revenue excluding interconnect revenue.
EQT is a purpose-driven global investment organization focused on active ownership strategies. With a Nordic heritage and a global mindset, EQT has a track record of almost three decades of delivering consistent and attractive returns across multiple geographies, sectors and strategies. Investor was one of the founders of EQT in 1994 and has committed capital to the vast majority of its funds. Read more at www.eqtgroup.com
Contribution to net asset value (adjusted and reported) amounted to SEK -40,370m during 2022 (63,988), of which SEK 1,216m during the fourth quarter (27,596).
The reported value change of Investor's investments in EQT was -35 percent during 2022, of which -37 percent in constant currency.
During the fourth quarter, the value change amounted to 2 percent, of which 1 percent in constant currency.
Net cash flow to Investor amounted to SEK 6,220m during 2022, of which SEK 1,426m during the fourth quarter.
Total shareholder return for 2022 amounted to -55 percent, of which 1 percent during the fourth quarter.
Dividends received amounted to SEK 488m during 2022, of which SEK 244m during the fourth quarter.
Investor reports the value change on its EQT fund investments with a one-quarter lag. Consequently, the information related to Investor's investments in EQT funds in this report is presented as of September 30, 2022.
During 2022, the reported value change of Investor's investments in EQT funds amounted to 21 percent, of which 13 percent in constant currency.
During the fourth quarter, the reported value change amounted to 2 percent, of which 1 percent in constant currency.
Investor's total outstanding commitments to EQT funds amounted to SEK 25.6bn as of December 31, 2022 (11.1).
| SEK m | Q4 2022 | 2022 | 2021 |
|---|---|---|---|
| Net asset value, beginning of period |
70,260 | 116,640 | 57,486 |
| Contribution to net asset value Drawdowns (investments, |
1,216 | -40,370 | 63,988 |
| management fees and management cost) |
832 | 4,000 | 8,068 |
| Proceeds to Investor (divestitures, fee surplus, carry and dividend) |
-2,257 | -10,220 | -12,902 |
| Net asset value, end of period | 70,050 | 70,050 | 116,640 |
| Fund size EUR m |
Share (%) | Outstanding commitment SEK m |
Reported value SEK m |
|||
|---|---|---|---|---|---|---|
| Fully invested funds2) | 38,019 | 3,291 | 14,612 | |||
| EQT IX | 15,600 | 3 | 1,079 | 5,698 | ||
| EQT Infrastructure IV | 9,100 | 3 | 637 | 3,282 | ||
| EQT Infrastructure V | 15,700 | 3 | 2,488 | 3,084 | ||
| Credit Opportunities III3) | 1,272 | 10 | 555 | 682 | ||
| EQT Growth | 2,200 | 3 | 546 | 147 | ||
| EQT Ventures II | 619 | 3 | 13 | 318 | ||
| EQT Ventures III | 1,000 | 3 | 287 | 62 | ||
| EQT Mid Market Asia III | 630 | 27 | 215 | 1,690 | ||
| EQT Mid Market Europe | 1,616 | 9 | 260 | 1,774 | ||
| EQT Real Estate II | 1,000 | 3 | 183 | 163 | ||
| EQT new funds | - | - | 16,052 | 38 | ||
| Total fund investments | 86,756 | 25,607 | 31,550 | |||
| EQT AB | 14.6/14.74) | 38,500 | ||||
| Total investments in EQT | 70,050 | |||||
Investor
1) Following the IPO of EQT AB in September 2019, Investor's investments in EQT funds are reported with a one-quarter lag. 2) EQT V, EQT VI, EQT VII, EQT VIII, EQT Expansion Capital II, EQT Greater China II, EQT Infrastructure I, II, III and IV, EQT Credit Fund II, EQT Mid Market, EQT Mid Market US, EQT Real Estate I, EQT Ventures.
3) Divested by EQT AB to Bridgepoint, October 2020.
4) Capital and votes respectively.
| SEK m | FY 2022 |
Q4 2022 |
Q3 2022 |
Q2 2022 |
Q1 2022 |
FY 2021 |
Q4 2021 |
Q3 2021 |
Q2 2021 |
Q1 2021 |
FY 2020 |
Q4 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported value | 70,050 | 70,050 | 70,260 | 69,647 | 99,078 | 116,640 | 116,640 | 90,889 | 78,467 | 75,566 | 57,486 | 57,486 |
| Reported value change, % |
-35 | 2 | 2 | -26 | -15 | 111 | 30 | 16 | 9 | 30 | 55 | 16 |
| Value change, constant currency, % |
-37 | 1 | 1 | -27 | -15 | 110 | 30 | 16 | 9 | 29 | 57 | 18 |
| Drawdowns from Investor |
4,000 | 832 | 428 | 847 | 1,893 | 8,068 | 3,120 | 2,258 | 1,169 | 1,520 | 4,630 | 377 |
| Proceeds to Investor | 10,220 | 2,257 | 1,355 | 4,660 | 1,947 | 12,902 | 4,965 | 2,550 | 4,986 | 401 | 4,801 | 908 |
| Net cash flow to Investor |
6,220 | 1,426 | 927 | 3,813 | 54 | 4,834 | 1,845 | 292 | 3,817 | -1,119 | 171 | 531 |
Net debt totaled SEK 10,263m on December 31, 2022 (14,491). Debt financing of the Patricia Industries' subsidiaries is arranged without guarantees from Investor and hence not included in Investor's net debt. Investor guarantees SEK 2.4bn of the associated company Three Scandinavia's refinanced external debt, but this guaranteed loan is not included in Investor's net debt either. The same applies for pending dividends from investments and approved but not yet paid dividend to shareholders.
| SEK m | Consolidated balance sheet |
Deductions related to Patricia Industries |
Investor's net debt |
|---|---|---|---|
| Other financial investments Cash, bank and short |
9,705 | -116 | 9,590 |
| term investments Receivables included |
26,304 | -7,361 | 18,943 |
| in net debt | 945 | -148 | 797 |
| Interest bearing debt | -91,220 | 51,728 | -39,492 |
| Provision for pensions | -799 | 699 | -101 |
| Total | -55,065 | 44,802 | -10,263 |
Investor's gross cash amounted to SEK 28,533m as of December 31, 2022 (23,955). The short-term investments are invested conservatively, taking into account the riskadjusted return profile. Investor's gross debt, excluding pension liabilities, amounted to SEK 38,695m as of December 31, 2022 (38,337).
The average maturity of Investor AB's debt portfolio was 11.8 years on December 31, 2022 (10.8), excluding the debt of the Patricia Industries subsidiaries.
Investor is rated AA- (Stable Outlook) by S&P Global and Aa3 (Stable Outlook) by Moody's.
In January 2023, a SEK 8bn (10) revolving credit facility was refinanced and its maturity extended by five years, with an option of another two years' additional extension. The facility remains undrawn.

| SEK m | Group - Net financial items |
Deductions related to Patricia Industries |
Investor's net financial items |
|---|---|---|---|
| Interest income | 81 | -18 | 62 |
| Interest expenses Results from revaluation of loans, swaps and short |
-2,489 | 1,574 | -915 |
| term investments | -602 | 58 | -543 |
| Foreign exchange result | -2,951 | 461 | -2,490 |
| Other | -300 | 246 | -53 |
| Total | -6,261 | 2,321 | -3,940 |
Investor's share capital amounted to SEK 4,795m on December 31, 2022 (4,795).
| Share structure | |||||||
|---|---|---|---|---|---|---|---|
| Class of share |
Number of shares |
Number of votes |
% of capital |
% of votes |
|||
| A 1 vote | 1,246,763,376 | 1,246,763,376 | 40.6 | 87.2 | |||
| B 1/10 vote | 1,821,936,744 | 182,193,674 | 59.4 | 12.8 | |||
| Total | 3,068,700,120 | 1,428,957,050 | 100.0 | 100.0 |
Investor's share capital consists of 3,068,700,120 shares with a quota of SEK 1.5625 per share.
On December 31, 2022, Investor owned a total of 5,654,344 of its own shares (5,242,353).
The Parent Company's result after financial items was SEK -28,395m (136,791). The result is mainly related to Listed Companies which contributed to the result with dividends amounting to SEK 10,224m (10,286) and value changes of SEK -34,990m (126,711).
During 2022, the Parent Company invested SEK 3,349m in financial assets (3,621), of which SEK 495m in Group companies (0) and purchases in Listed Companies of SEK 501m (1,520). The Parent Company divested SEK 8,650m in Group Companies (800) and SEK 1,662m (519) in Listed Companies during the year. By the end of the period, Shareholder's equity totaled SEK 431,034m (471,763).
Investor AB's Annual General Meeting will be held on May 3, 2023, at 3:00 p.m. at China Teatern, Berzelii Park 9, Stockholm, Sweden. Notification of participation in the Annual General Meeting can be made from March 24, 2023. Additional information about Investor's Annual General Meeting will be available on Investor's website. Investor's audited Annual Report in Swedish will be made available at the company's head office and website no later than April 12, 2023.
The Board of Directors proposes a dividend to the shareholders of SEK 4.40 per share for fiscal year 2022 (4.00). The dividend is proposed to be paid out in two
installments, SEK 3.30 with record date May 5, 2023 and SEK 1.10 with record date November 6, 2023. Should the Annual General Meeting decide in favor of the proposal, payment of the dividend is expected to be made on May 10, 2023, and on November 9, 2023. The dividend level proposed is based on the stated dividend policy to pay a steadily rising dividend, supported by cash flow from our three business areas: Listed Companies, Patricia Industries and Investments in EQT.
Piab's acquisition of AVAC Vakuumteknik
On August 9, 2022 Piab finalized the acquisition of AVAC Vakuumteknik AB, a vacuum automation specialist company. The consideration amounted to SEK 23m. In the preliminary purchase price allocation, goodwill amounted to SEK 15m. AVAC complements Piab with a solid portfolio of products and solutions covering a wide range of applications, a highly experienced and skilled team as well as new customers. The goodwill recognized is not expected to be deductible for income tax purposes. Transaction related costs amounted to SEK 1m and derive from external legal fees and due diligence expenses. These costs have been included in the line item Administrative, research and development and other operating cost in the Group's consolidated income statement. For the period from the acquisition date until December 31, 2022, AVAC contributed net sales of SEK 4m and profit/loss of SEK 1m to the Group's result. If the acquisition had occurred on January 1, 2022, management estimates that consolidated net sales for the Group would have increased by SEK 9m and consolidated profit/loss for the period would have increased by SEK 1m.
On August 1, 2022, Advanced Instruments completed the acquisition of SAL Scientific Ltd, a private company that develops and manufactures a portfolio of cell growth supplements. The consideration amounted to SEK 62m. In the preliminary purchase price allocation, goodwill amounted to SEK 0m. The acquisition will support the expansion of regent technologies and deliver additional inhouse capabilities that support ongoing technology adoption, new product innovation and enhanced customer support. Transaction related costs amounted to SEK 2m and derive from external legal fees and due diligence expenses. These costs have been included in the line item Administrative, research and development and other operating cost in the Group's consolidated income statement. For the period from the acquisition date until December 31, 2022, SAL contributed net sales of SEK 0m and profit/loss of SEK 1m to the Group's result. If the acquisition had occurred on January 1, 2022, management estimates that consolidated net sales for the Group would have increased by SEK 0m and consolidated profit/loss for the period would have increased by SEK 1m.
On June 13, 2022, Advanced Instruments completed the acquisition of Artel, a leading provider of calibration and validation instruments, consumables, software and services used by life science laboratories. The consideration amounted to SEK 797m. In the preliminary purchase price allocation, goodwill amounted to SEK 639m. The goodwill recognized for the acquisition corresponds to the complementary strengths of the companies. The goodwill recognized is not expected to be deductible for income tax purposes. Transaction related costs amounted to SEK 29m and derive from external legal fees and due diligence expenses. These costs have
been included in the line item Administrative, research and development and other operating cost in the Group's consolidated income statement. For the period from the acquisition date until December 31, 2022, Artel contributed net sales of SEK 116m and profit/loss of SEK 13m to the Group's result. If the acquisition had occurred on January 1, 2022, management estimates that consolidated net sales for the Group would have increased by SEK 97m and consolidated profit/loss for the period would have increased by SEK 11m.
On May 19, 2022, Piab completed the acquisition of 95 percent of Joulin, a French provider of vacuum grippers and gantry robots for automated wood handling and other segments. The consideration amounted to SEK 622m. In the preliminary purchase price allocation, goodwill amounted to SEK 530m. The goodwill recognized for the acquisition corresponds to the complementary strengths of the companies. The goodwill recognized is not expected to be deductible for income tax purposes. Transaction related costs amounted to SEK 8m and derive from external legal fees and due diligence expenses. These costs have been included in the line item Administrative, research and development and other operating cost in the Group's consolidated income statement. For the period from the acquisition date until December 31, 2022, Joulin contributed net sales of SEK 94m and profit/loss of SEK 19m to the Group's result. If the acquisition had occurred on January 1, 2022, management estimates that consolidated net sales for the Group would have increased by SEK 62m and consolidated profit/loss for the period would have increased by SEK 21m.
On February 9, 2022, Piab completed the acquisition of Manut-LM, a French leading tube lifting company. The consideration amounted to SEK 75m. In the preliminary purchase price allocation, goodwill amounted to SEK 56m. The goodwill recognized for the acquisition corresponds to the complementary strengths of the companies. The goodwill recognized is not expected to be deductible for income tax purposes. Transaction related costs amounted to SEK 1m and derive from external legal fees and due diligence expenses. These costs have been included in the line item Administrative, research and development and other operating cost in the Group's consolidated income statement. For the period from the acquisition date until December 31, 2022, Manut-LM contributed net sales of SEK 53m and profit/loss of SEK 2m to the Group's result. If the acquisition had occurred on January 1, 2022, management estimates that consolidated net sales for the Group would have increased by SEK 9m and consolidated profit/loss for the period would have increased by SEK 1m.
On January 3, 2022, Permobil completed the acquisition of Panthera, a leading company in ultra-light active wheelchairs. The consideration amounted to SEK 305m. In the final purchase price allocation, goodwill amounted to SEK 241m. The goodwill recognized for the acquisition corresponds to the complementary strengths of the companies' product portfolios. The goodwill recognized is not expected to be deductible for income tax purposes. Transaction related costs amounted to SEK 6m and derive from external legal fees and due diligence expenses. These costs have been included in the line item Administrative, research and development and other operating cost in the Group's consolidated income statement. For the period from the acquisition date until December 31, 2022, Panthera contributed net sales of
| SEK m | AVAC | SAL | Artel | Joulin | Manut-LM Panthera | Total | |
|---|---|---|---|---|---|---|---|
| Intangible assets | - | 78 | 499 | 0 | 1 | 0 | 578 |
| Property, plant and equipment | 2 | - | 63 | 4 | 3 | 9 | 81 |
| Other financial investments | - | - | - | 0 | 0 | 6 | 6 |
| Inventories | 3 | 1 | 43 | 36 | 9 | 48 | 140 |
| Trade receivables | 2 | 1 | 35 | 21 | 15 | 19 | 93 |
| Other current receivables | 0 | 0 | 5 | 2 | 1 | 1 | 10 |
| Cash and cash equivalents | 3 | 5 | 56 | 87 | 21 | 25 | 197 |
| Long-term interest bearing liabilities | - | -2 | -47 | - | -6 | -16 | -72 |
| Deferred tax liabilities | - | -19 | -129 | - | - | -4 | -151 |
| Other liabilities | -2 | -1 | -368 | -28 | -25 | -24 | -448 |
| Net identifiable assets and liabilities | 8 | 62 | 158 | 123 | 20 | 64 | 435 |
| Non-controlling interest | - | - | - | -31 | - | - | -31 |
| Consolidated goodwill | 15 | - | 639 | 530 | 56 | 241 | 1,481 |
| Consideration | 23 | 62 | 797 | 622 | 75 | 305 | 1,885 |
Total pledged assets amount to SEK 29.8bn (24.8), of which SEK 27.5bn (23.4) refers to pledged assets in the subsidiaries BraunAbility, Laborie, Advanced Instruments and Sarnova, related to outstanding loans corresponding to SEK 2.6bn, SEK 4.6bn, SEK 2.1bn and SEK 5.3bn. The increase in pledged assets mainly relates to increased assets in the subsidiaries.
Total contingent liabilities amount to SEK 1.6bn and refers to warranties within the wholly-owned subsidiaries (1.1).
The main risks that the Group and the Parent Company are exposed to are primarily related to the value changes of the listed assets due to market price fluctuations. The current uncertain market environment creates unpredictable near-term fluctuations in the financial markets. The global market development also affects Investor's unlisted holdings' businesses. The global economy continues to be affected by geopolitical tensions, Russia's invasion of Ukraine, supply chain constraints as well as increased inflation and interest. Investor's portfolio companies operate in several different industries, and they all face different situations. Based on Investor's governance model, each individual board and management team decides on appropriate actions related to the company's risks.
All companies have taken measures related to Russia's invasion of Ukraine to follow sanctions, to protect and support employees, and several have wound down their Russian activities. The direct exposure to Russia and Ukraine is very small for Investor and its subsidiaries and the direct financial impact from the war is negligible. However, the indirect impact due to fluctuations in the financial markets, higher prices on raw materials, inflation and central bank policies, can be substantial, but it is not possible to quantify these effects for the coming year. In 2022, Investor's net sales to Russia and Ukraine amounted to SEK 75m, corresponding to 0.14 percent of net sales for the Group. The Group has no production plants or other assets in the countries concerned. During 2022 no impairment has been made related to Russia's invasion of Ukraine.
Investor's risk management, risks and uncertainties are described more in detail in the Annual Report, (Administration report and Note 3).
For the Group, this Year-End Report is prepared in accordance with IAS 34 Interim Financial Reporting and applicable regulations in the Swedish Annual Accounts Act, and for the Parent Company in accordance with Sweden's Annual Accounts Act, chapter 9 Interim report. The accounting policies that have been applied for the Group and Parent Company, are in agreement with the accounting policies used in preparation of the company's most recent annual report.
Investor applies the ESMA Guidelines on Alternative Performance Measures (APMs). An APM is a financial measure of historical or future financial performance, financial position, or cash flows, other than a financial measure defined or specified in the applicable financial reporting framework. For Investor's consolidated accounts, this framework typically means IFRS.
Definitions of all APMs used are found in the Annual Report 2021 and on www.investorab.com/investorsmedia/investor-in-figures/definitions.
Reconciliations to the financial statements for the APMs that are not directly identifiable from the financial statements and considered significant to specify, are disclosed on pages 30-31. Reconciliations of APMs for individual subsidiaries or business areas are not disclosed, since the purpose of these are to give deeper financial information without being directly linked to the financial information for the Group, that is presented according to the applicable financial reporting framework.
Due to rounding, numbers presented throughout this Year-End Report may not add up precisely to the totals provided and percentages may not precisely reflect the absolute figures.
| Apr. 21, 2023 | Interim Management Statement January-March 2023 |
|---|---|
| May 3, 2023 | Annual General Meeting |
| Jul. 17, 2023 | Interim Report January-June 2023 |
| Oct. 19, 2023 | Interim Management Statement January-September 2023 |
Jan. 19, 2024 Year-End Report 2023
Stockholm, January 20, 2023
Johan Forssell President and Chief Executive Officer
Helena Saxon Chief Financial Officer +46 8 614 2000 [email protected]
Viveka Hirdman-Ryrberg Head of Corporate Communication and Sustainability +46 70 550 3500 [email protected]
Magnus Dalhammar Head of Investor Relations +46 73 524 2130 [email protected]
Investor AB (publ) (CIN 556013-8298) SE-103 32 Stockholm, Sweden Visiting address: Arsenalsgatan 8C Phone: +46 8 614 2000 www.investorab.com
Ticker codes
INVEB SS in Bloomberg INVEb.ST in Reuters INVE B in NASDAQ OMX
Information about Investor is also available on LinkedIn.
This information is information that Investor AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 08:15 CET on January 20, 2023.
This Year-End Report and additional information is available on www.investorab.com
We have reviewed the Interim report of Investor AB (publ), corporate identity number 556013-8298, for the period January 1-December 31, 2022. The Board of Directors and the President are responsible for the preparation and presentation of this interim report in accordance with IAS 34 and the Annual Accounts Act. Our responsibility is to express a conclusion on this interim report based on our review.
We conducted our review in accordance with the International Standard on Review Engagements ISRE 2410, Review of Interim Financial Information Performed by the Independent Auditor of the Entity. A review consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review has a different focus and is substantially less in scope than an audit conducted in accordance with International Standards on Auditing (ISA) and other generally accepted auditing practices. The procedures performed in a review do not enable us to obtain a level of assurance that would
make us aware of all significant matters that might be identified in an audit.
Therefore, the conclusion expressed based on a review does not give the same level of assurance as a conclusion expressed based on an audit.
Based on our review, nothing has come to our attention that causes us to believe that the Interim report is not, in all material respects, prepared for the Group in accordance with IAS 34 and the Annual Accounts Act, and for the Parent Company in accordance with the Annual Accounts Act.
Stockholm, January 20, 2023
Deloitte AB
For signature, please see Swedish version
Jonas Ståhlberg
Authorized Public Accountant
| SEK m | 2022 | 2021 | H2 2022 | H2 2021 | Q4 2022 | Q4 2021 |
|---|---|---|---|---|---|---|
| Dividends | 11,427 | 11,254 | 2,974 | 4,397 | 1,661 | 3,346 |
| Changes in value | -82,783 | 213,505 | 58,602 | 104,178 | 51,046 | 77,903 |
| Net sales | 51,812 | 40,737 | 27,883 | 21,393 | 14,168 | 11,037 |
| Cost of goods and services sold | -28,546 | -21,743 | -15,434 | -11,602 | -7,876 | -5,997 |
| Sales and marketing cost | -7,708 | -6,072 | -4,093 | -3,173 | -2,130 | -1,631 |
| Administrative, research and development and other operating cost |
-9,824 | -8,420 | -5,030 | -4,833 | -2,591 | -2,124 |
| Management cost | -624 | -530 | -340 | -277 | -188 | -158 |
| Share of results of associates | -1,176 | 2,938 | -1,184 | 75 | -1,200 | -20 |
| Operating profit/loss | -67,423 | 231,669 | 63,378 | 110,158 | 52,889 | 82,356 |
| Net financial items | -6,261 | -3,347 | -2,768 | -1,985 | -773 | -1,141 |
| Profit/loss before tax | -73,684 | 228,322 | 60,610 | 108,173 | 52,116 | 81,215 |
| Income taxes | -1,079 | -357 | -726 | -147 | -550 | -124 |
| Profit/loss for the period | -74,762 | 227,965 | 59,884 | 108,027 | 51,567 | 81,091 |
| Attributable to: | ||||||
| Owners of the Parent Company | -74,681 | 228,065 | 59,901 | 108,064 | 51,529 | 81,098 |
| Non-controlling interest | -81 | -100 | -17 | -38 | 38 | -7 |
| Profit/loss for the period | -74,762 | 227,965 | 59,884 | 108,027 | 51,567 | 81,091 |
| Basic earnings per share, SEK | -24.38 | 74.45 | 19.56 | 35.28 | 16.82 | 26.47 |
| Diluted earnings per share, SEK | -24.38 | 74.41 | 19.55 | 35.26 | 16.81 | 26.46 |
Consolidated Statement of Comprehensive Income, in summary
| SEK m | 2022 | 2021 | H2 2022 | H2 2021 | Q4 2022 | Q4 2021 |
|---|---|---|---|---|---|---|
| Profit/loss for the period | -74,762 | 227,965 | 59,884 | 108,027 | 51,567 | 81,091 |
| Other comprehensive income for the period, including tax | ||||||
| Revaluation of property, plant and equipment | 13 | 21 | 13 | 21 | 13 | 21 |
| Re-measurements of defined benefit plans | 254 | 46 | 188 | 25 | 190 | 26 |
| Items that may be recycled to profit/loss for the period | ||||||
| Cash flow hedges | 76 | 68 | 26 | 25 | 3 | 14 |
| Hedging costs | 121 | -12 | 44 | 5 | -43 | -13 |
| Foreign currency translation adjustment | 8,954 | 3,518 | 2,657 | 2,162 | -1,533 | 996 |
| Share of other comprehensive income of associates | 132 | 28 | 72 | 34 | -8 | 23 |
| Total other comprehensive income for the period | 9,550 | 3,668 | 3,000 | 2,273 | -1,377 | 1,067 |
| Total comprehensive income for the period | -65,212 | 231,633 | 62,884 | 110,299 | 50,189 | 82,158 |
| Attributable to: | ||||||
| Owners of the Parent Company | -65,175 | 231,708 | 62,891 | 110,319 | 50,161 | 82,149 |
| Non-controlling interest | -37 | -74 | -7 | -20 | 28 | 9 |
| Total comprehensive income for the period | -65,212 | 231,633 | 62,884 | 110,299 | 50,189 | 82,158 |
| Consolidated Balance Sheet, in summary | ||
|---|---|---|
| SEK m | 12/31 2022 | 12/31 2021 |
| ASSETS | ||
| Goodwill | 63,334 | 55,437 |
| Other intangible assets | 34,355 | 33,168 |
| Property, plant and equipment | 16,239 | 14,044 |
| Shares and participations | 550,556 | 638,336 |
| Other financial investments | 9,705 | 14,778 |
| Long-term receivables included in net debt | 945 | 1,964 |
| Other long-term receivables | 2,873 | 2,727 |
| Total non-current assets | 678,006 | 760,454 |
| Inventories | 9,583 | 6,767 |
| Shares and participations in trading operation | 873 | 375 |
| Other current receivables | 9,598 | 9,412 |
| Cash, bank and short-term investments | 26,304 | 18,534 |
| Total current assets | 46,358 | 35,088 |
| TOTAL ASSETS | 724,365 | 795,542 |
| EQUITY AND LIABILITIES | ||
| Equity | 605,653 | 683,505 |
| Long-term interest bearing liabilities | 89,436 | 83,966 |
| Provisions for pensions and similar obligations | 799 | 1,068 |
| Other long-term provisions and liabilities | 14,973 | 13,026 |
| Total non-current liabilities | 105,209 | 98,059 |
| Current interest bearing liabilities | 1,783 | 3,255 |
| Other short-term provisions and liabilities | 11,719 | 10,722 |
| Total current liabilities | 13,502 | 13,977 |
| TOTAL EQUITY AND LIABILITIES | 724,365 | 795,542 |
| SEK m | 2022 | 2021 |
|---|---|---|
| Opening balance 1/1 | 683,505 | 462,775 |
| Profit for the period | -74,762 | 227,965 |
| Other comprehensive income for the period | 9,550 | 3,668 |
| Total comprehensive income for the period | -65,212 | 231,633 |
| Dividend to shareholders | -12,254 | -10,722 |
| Changes in non-controlling interest | -282 | -991) |
| Effect of long-term share-based remuneration | 42 | 64 |
| Purchase of own shares | -147 | -147 |
| Closing balance | 605,653 | 683,505 |
| 1) Includes reclassification of non-controlling interest amounting to SEK -620m. | ||
| Attributable to: | ||
| Owners of the Parent Company | 604,865 | 682,614 |
| Non-controlling interest | 788 | 891 |
| Total equity | 605,653 | 683,505 |
| Consolidated Cash Flow, in summary | ||
|---|---|---|
| SEK m | 2022 | 2021 |
| Operating activities | ||
| Dividends received | 11,507 | 11,254 |
| Cash receipts | 50,099 | 39,488 |
| Cash payments | -41,315 | -32,904 |
| Cash flows from operating activities before net interest and income tax | 20,291 | 17,838 |
| Interest received/paid | -2,570 | -2,143 |
| Income tax paid | -1,111 | -1,440 |
| Cash flows from operating activities | 16,610 | 14,256 |
| Investing activities | ||
| Acquisitions1) | -4,434 | -9,695 |
| Divestments2) | 11,696 | 16,779 |
| Increase in long-term receivables | -184 | -93 |
| Decrease in long-term receivables | 38 | 101 |
| Divestments of associated companies | - | 2,126 |
| Acquisitions of subsidiaries, net effect on cash flow | -2,318 | -8,915 |
| Divestments of subsidiaries, net effect on cash flow | 83 | 4,079 |
| Increase in other financial investments3) | -9,534 | -25,603 |
| Decrease in other financial investments4) | 14,292 | 14,103 |
| Net change, short-term investments5) | -13,102 | 8,079 |
| Acquisitions of property, plant and equipment | -4,368 | -3,799 |
| Proceeds from sale of property, plant and equipment | 373 | 68 |
| Net cash used in investing activities | -7,458 | -2,772 |
| Financing activities | ||
| New share issue | 21 | 494 |
| Borrowings | 13,273 | 6,172 |
| Repayment of borrowings | -15,965 | -8,968 |
| Repurchases of own shares | -147 | -149 |
| Dividend paid | -12,286 | -10,722 |
| Net cash used in financing activities | -15,104 | -13,174 |
| Cash flows for the period | -5,952 | -1,690 |
| Cash and cash equivalents at the beginning of the year | 18,330 | 19,670 |
| Exchange difference in cash | 787 | 350 |
| Cash and cash equivalents at the end of the period | 13,164 | 18,330 |
1) Acquisitions include investments in listed and unlisted companies not defined as subsidiaries.
2) Divestments include sale of listed and unlisted companies not defined as subsidiaries.
3) Increase in other financial investments include acquisition of bond with maturity later than 1 year.
4) Decrease in other financial investments include disposals of reclassification of bonds with maturity later than 1 year.
5) Net changes, short-term investments includes acquisitions and disposals of bonds and certificates with maturity within 1 year.
| SEK m | Listed Companies |
Patricia Industries |
Investments in EQT |
Investor Groupwide |
Total |
|---|---|---|---|---|---|
| Dividends | 1,416 | - | 244 | 0 | 1,661 |
| Changes in value | 50,895 | -326 | 461 | 16 | 51,046 |
| Net sales | - | 14,168 | - | - | 14,168 |
| Cost of goods and services sold | - | -7,876 | - | - | -7,876 |
| Sales and marketing cost | - | -2,130 | - | - | -2,130 |
| Administrative, research and development and other operating cost | - | -2,581 | -2 | -8 | -2,591 |
| Management cost | -45 | -96 | -3 | -44 | -188 |
| Share of results of associates | - | -1,200 | - | - | -1,200 |
| Operating profit/loss | 52,267 | -41 | 700 | -36 | 52,889 |
| Net financial items | - | -20 | - | -752 | -773 |
| Income tax | - | -609 | - | 59 | -550 |
| Profit/loss for the period | 52,267 | -670 | 700 | -729 | 51,567 |
| Non-controlling interest | - | -37 | - | 0 | -38 |
| Net profit/loss for the period attributable to the Parent Company | 52,267 | -708 | 700 | -729 | 51,529 |
| Other effects on equity | - | -1,923 | 516 | 60 | -1,347 |
| Contribution to net asset value | 52,267 | -2,631 | 1,216 | -670 | 50,182 |
| Net asset value by business area 12/31 2022 | |||||
| Carrying amount | 475,296 | 70,110 | 70,050 | -328 | 615,128 |
| Investors net debt/-cash | - | 11,823 | - | -22,086 | -10,263 |
| Total net asset value including net debt/-cash | 475,296 | 81,933 | 70,050 | -22,413 | 604,865 |
| SEK m | Listed Companies |
Patricia Industries |
Investments in EQT |
Investor Groupwide |
Total |
|---|---|---|---|---|---|
| Dividends | 3,134 | - | 209 | 3 | 3,346 |
| Changes in value | 50,220 | 366 | 27,329 | -12 | 77,903 |
| Net sales | - | 11,037 | - | - | 11,037 |
| Cost of goods and services sold | - | -5,997 | - | 0 | -5,997 |
| Sales and marketing cost | - | -1,631 | - | - | -1,631 |
| Administrative, research and development and other operating cost | 0 | -2,118 | -1 | -4 | -2,124 |
| Management cost | -34 | -69 | -3 | -52 | -158 |
| Share of results of associates | - | -20 | - | - | -20 |
| Operating profit/loss | 53,320 | 1,568 | 27,534 | -66 | 82,356 |
| Net financial items | - | -881 | - | -260 | -1,141 |
| Income tax | - | -152 | - | 28 | -124 |
| Profit/loss for the period | 53,320 | 535 | 27,534 | -297 | 81,091 |
| Non-controlling interest | - | 7 | - | 0 | 7 |
| Net profit/loss for the period attributable to the Parent Company | 53,320 | 542 | 27,534 | -297 | 81,098 |
| Other effects on equity | - | 882 | 62 | 9 | 953 |
| Contribution to net asset value | 53,320 | 1,424 | 27,596 | -289 | 82,051 |
| Net asset value by business area 12/31 2021 | |||||
| Carrying amount | 515,078 | 65,758 | 116,640 | -371 | 697,105 |
| Investors net debt/-cash | - | 12,505 | - | -26,997 | -14,491 |
| Total net asset value including net debt/-cash | 515,078 | 78,263 | 116,640 | -27,367 | 682,614 |
| Listed | Patricia | Investments in | Investor | ||
|---|---|---|---|---|---|
| SEK m | Companies | Industries | EQT | Groupwide | Total |
| Dividends | 10,935 | 1 | 488 | 3 | 11,427 |
| Changes in value | -38,638 | -825 | -43,306 | -14 | -82,783 |
| Net sales | - | 51,812 | - | - | 51,812 |
| Cost of goods and services sold | - | -28,546 | - | - | -28,546 |
| Sales and marketing cost | - | -7,708 | - | - | -7,708 |
| Administrative, research and development and other operating cost | - | -9,789 | -6 | -30 | -9,824 |
| Management cost | -148 | -336 | -11 | -130 | -624 |
| Share of results of associates | - | -1,176 | - | - | -1,176 |
| Operating profit/loss | -27,851 | 3,433 | -42,834 | -171 | -67,423 |
| Net financial items | - | -2,321 | - | -3,940 | -6,261 |
| Income tax | - | -1,080 | - | 1 | -1,079 |
| Profit/loss for the period | -27,851 | 32 | -42,834 | -4,109 | -74,762 |
| Non-controlling interest | - | 81 | - | 0 | 81 |
| Net profit/loss for the period attributable to the Parent Company | -27,851 | 113 | -42,834 | -4,110 | -74,681 |
| Dividend to shareholders | - | - | - | -12,254 | -12,254 |
| Other effects on equity | - | 6,531 | 2,464 | 191 | 9,186 |
| Contribution to net asset value | -27,851 | 6,645 | -40,370 | -16,173 | -77,749 |
| Net asset value by business area 12/31 2022 | |||||
| Carrying amount | 475,296 | 70,110 | 70,050 | -328 | 615,128 |
| Investors net debt/-cash | - | 11,823 | - | -22,086 | -10,263 |
| Total net asset value including net debt/-cash | 475,296 | 81,933 | 70,050 | -22,413 | 604,865 |
| Listed | Patricia | Investments in | Investor | ||
|---|---|---|---|---|---|
| SEK m | Companies | Industries | EQT | Groupwide | Total |
| Dividends | 10,834 | - | 418 | 2 | 11,254 |
| Changes in value | 148,616 | 1,722 | 63,174 | -6 | 213,505 |
| Net sales | - | 40,737 | - | - | 40,737 |
| Cost of goods and services sold | - | -21,743 | - | 0 | -21,743 |
| Sales and marketing cost | - | -6,072 | - | - | -6,072 |
| Administrative, research and development and other operating cost | 0 | -8,391 | -5 | -24 | -8,420 |
| Management cost | -123 | -261 | -9 | -136 | -530 |
| Share of results of associates | - | 2,938 | - | - | 2,938 |
| Operating profit/loss | 159,327 | 8,928 | 63,578 | -164 | 231,669 |
| Net financial items | - | -1,791 | - | -1,556 | -3,347 |
| Income tax | - | -312 | - | -45 | -357 |
| Profit/loss for the period | 159,327 | 6,825 | 63,578 | -1,765 | 227,965 |
| Non-controlling interest | - | 100 | - | 0 | 100 |
| Net profit/loss for the period attributable to the Parent Company | 159,327 | 6,926 | 63,578 | -1,765 | 228,065 |
| Dividend to shareholders | - | - | - | -10,722 | -10,722 |
| Other effects on equity | - | 2,968 | 410 | 56 | 3,435 |
| Contribution to net asset value | 159,327 | 9,894 | 63,988 | -12,431 | 220,778 |
| Net asset value by business area 12/31 2021 | |||||
| Carrying amount | 515,078 | 65,758 | 116,640 | -371 | 697,105 |
| Investors net debt/-cash | - | 12,505 | - | -26,997 | -14,491 |
| Total net asset value including net debt/-cash | 515,078 | 78,263 | 116,640 | -27,367 | 682,614 |
| Parent Company Income Statement, in summary | ||||
|---|---|---|---|---|
| SEK m | 2022 | 2021 | H2 2022 | H2 2021 |
| Dividends | 10,224 | 10,286 | 2,357 | 3,904 |
| Changes in value | -35,006 | 128,188 | 49,639 | 55,886 |
| Net sales | 15 | 10 | 7 | 6 |
| Operating cost | -468 | -420 | -247 | -222 |
| Operating profit/loss | -25,236 | 138,063 | 51,756 | 59,573 |
| Profit/loss from financial items | ||||
| Net financial items | -3,159 | -1,273 | -1,936 | -636 |
| Profit/loss after financial items | -28,395 | 136,791 | 49,820 | 58,937 |
| Income tax | - | - | - | - |
| Profit/loss for the period | -28,395 | 136,791 | 49,820 | 58,937 |
| Parent Company Balance Sheet, in summary | ||
|---|---|---|
| SEK m | 12/31 2022 | 12/31 2021 |
| ASSETS | ||
| Intangible assets and Property, plant and equipment | 18 | 18 |
| Financial assets | 487,756 | 529,377 |
| Total non-current assets | 487,774 | 529,395 |
| Current receivables | 489 | 379 |
| Cash and cash equivalents | - | - |
| Total current assets | 489 | 379 |
| TOTAL ASSETS | 488,263 | 529,773 |
| EQUITY AND LIABILITIES | ||
| Equity | 431,034 | 471,763 |
| Provisions | 128 | 137 |
| Non-current liabilities, interest bearing | 45,940 | 44,625 |
| Total non-current liabilities | 46,068 | 44,762 |
| Current liabilities, interest bearing | 0 | 946 |
| Current liabilities | 11,160 | 12,303 |
| Total current liabilities | 11,160 | 13,249 |
| TOTAL EQUITY AND LIABILITIES | 488,263 | 529,773 |
The numbers below are based on the same accounting and valuation policies as used in the preparation of the company's most recent annual report. For information regarding financial instruments in level 2 and level 3, see Note 31, Financial Instruments, in Investor's Annual Report 2021.
| Fair value, SEK m | Range | |||||
|---|---|---|---|---|---|---|
| Group | 12/31 2022 | 12/31 2021 | Valuation technique | Input | 12/31 2022 | 12/31 2021 |
| Shares and participations | 34,184 | 33,756 | Last round of financing | n/a | n/a | n/a |
| Comparable companies | EBITDA multiples | n/a | n/a | |||
| Comparable companies | Sales multiples | 0.9 – 3.3 | 3.1 – 4.4 | |||
| Comparable transactions | Sales multiples | 1.2 – 2.5 | 2.2 – 3.6 | |||
| NAV | n/a | n/a | n/a | |||
| Other financial investments | 25 | 160 | Discounted cash flow | Market interest rate | n/a | n/a |
| Long-term and current receivables | 2,543 | 3,745 | Discounted cash flow | Market interest rate | n/a | n/a |
| Long-term interest bearing liabilities | 17 | 46 | Discounted cash flow | Market interest rate | n/a | n/a |
| Other provisions and liabilities | 6,735 | 6,036 | Discounted cash flow | n/a | n/a | n/a |
All valuations in level 3 are based on assumptions and judgments that management considers to be reasonable based on the circumstances prevailing at the time. Changes in assumptions may result in adjustments to reported values and the actual outcome may differ from the estimates and judgments that were made. Shares and participations in level 3 are mainly fund investments within EQT. Unlisted holdings in funds are measured at Investor's share of the value that the fund manager reports for all unlisted fund holdings (Net Asset Value) and is normally updated when a new valuation is received. The value change on Investor's investments in EQT funds are reported with a one-quarter lag. Part of the unlisted portfolio is valued based on comparable companies, and the value is dependent on the level of the multiples. The multiple ranges provided in the note show the minimum and maximum value of the actual multiples applied in these valuations. A 10 percent change of the multiples would have an effect on this part of the unlisted portfolio of approximately SEK 200m (120). For the derivatives, a parallel shift of the interest rate curve by one percentage point would affect the value by approximately SEK 660m (900).
The table below indicates how fair value is measured for the financial instruments recognized at fair value in the Balance Sheet. The financial instruments are presented in three categories, depending on how the fair value is measured: Level 1: According to quoted prices in active markets for identical instruments
Level 2: According to directly or indirectly observable inputs that are not included in level 1
Level 3: According to inputs that are unobservable in the market
| 12/31 2022 | 12/31 2021 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Group | Total carrying |
Total carrying |
||||||||
| SEK m | Level 1 | Level 2 | Level 3 | Other1) | amount | Level 1 | Level 2 | Level 3 | Other1) | amount |
| Financial assets | ||||||||||
| Shares and participations | 511,703 | 2,167 | 34,184 | 2,502 | 550,556 | 598,769 | 2,355 | 33,756 | 3,456 | 638,336 |
| Other financial investments | 9,591 | - | 25 | 89 | 9,705 | 14,543 | - | 160 | 75 | 14,778 |
| Long-term receivables included in net debt |
- | - | 945 | - | 945 | - | - | 1,964 | - | 1,964 |
| Other long-term receivables | - | - | 1,598 | 1,275 | 2,873 | - | - | 1,781 | 946 | 2,727 |
| Shares and participations in trading operation |
873 | - | - | - | 873 | 375 | - | - | - | 375 |
| Other current receivables | 0 | 41 | - | 9,557 | 9,598 | 22 | 1 | - | 9,389 | 9,412 |
| Cash, bank and short-term investments |
18,767 | - | - | 7,537 | 26,304 | 9,356 | - | - | 9,178 | 18,534 |
| Total | 540,935 | 2,208 | 36,752 | 20,960 | 600,855 | 623,065 | 2,357 | 37,661 | 23,043 | 686,125 |
| Financial liabilities | ||||||||||
| Long-term interest bearing liabilities |
- | - | 17 | 89,420 | 89,4362) | - | - | 46 | 83,920 | 83,9662) |
| Other long-term provisions and liabilities |
- | - | 6,692 | 8,282 | 14,973 | - | - | 5,935 | 7,091 | 13,026 |
| Short-term interest bearing liabilities |
- | 48 | - | 1,735 | 1,7833) | - | 228 | - | 3,027 | 3,2553) |
| Other short-term provisions and liabilities |
179 | 77 | 44 | 11,419 | 11,719 | 117 | 131 | 101 | 10,373 | 10,722 |
| Total | 179 | 125 | 6,752 | 110,856 | 117,912 | 117 | 359 | 6,082 | 104,411 | 110,969 |
1) To enable reconciliation with balance sheet items, financial instruments not valued at fair value as well as other assets and liabilities that are included within balance sheet items
have been included within Other. 2) The Group's loans are valued at amortized cost. Fair value on long-term loans amounts to SEK 80,997m (88,354).
3) The Group's loans are valued at amortized cost. Fair value on short-term loans amounts to SEK 1,783m (3,262).
| Other | Long-term receivables |
Long-term interest |
Other long term |
Other | ||
|---|---|---|---|---|---|---|
| SEK m | Shares and participations |
financial investments |
included in net debt |
bearing liabilities |
provisions and liabilities |
current liabilities |
| Opening balance at the beginning of the year | 33,756 | 160 | 3,745 | 46 | 5,935 | 101 |
| Total gain or losses in profit or loss statement | ||||||
| in line Changes in value | 3,789 | -26 | -139 | - | -1 | - |
| in line Net financial items | - | -4 | -1,168 | -29 | 209 | -55 |
| in line Cost of goods and services sold | 0 | - | - | - | -4 | - |
| Reported in other comprehensive income | ||||||
| in line Cash flow hedges | - | - | 144 | |||
| in line Foreign currency translation adjustment | 3,308 | 18 | 44 | - | 562 | 1 |
| Acquisitions | 3,671 | - | - | - | - | - |
| Divestments | -10,341 | -116 | - | - | - | - |
| Issues | - | - | 11 | - | - | - |
| Settlements | - | - | -95 | - | -9 | -3 |
| Transfer out of Level 3 | - | -6 | - | - | - | - |
| Carrying amount at end of the period | 34,184 | 25 | 2,543 | 17 | 6,692 | 44 |
| Total unrealized gains/losses for the period included in profit/loss for financial instruments held at the end of the period |
||||||
| Changes in value | -2,435 | - | - | - | -65 | - |
| Net financial items | - | - | -1,168 | 29 | - | - |
| Total | -2,435 | - | -1,168 | 29 | -65 | - |
| Other | Long-term receivables |
Long-term interest |
Other long term |
Other | ||
|---|---|---|---|---|---|---|
| SEK m | Shares and participations |
financial investments |
included in net debt |
bearing liabilities |
provisions and liabilities |
current liabilities |
| Opening balance at the beginning of the year | 24,409 | 120 | 3,586 | 59 | 4,179 | 117 |
| Total gain or losses in profit or loss statement | ||||||
| in line Changes in value | 13,271 | 23 | 228 | - | -113 | - |
| in line Net financial items | - | -11 | -50 | -14 | 680 | 8 |
| Reported in other comprehensive income | ||||||
| in line Foreign currency translation adjustment | 813 | 13 | 10 | - | 226 | 0 |
| Acquisitions | 7,386 | 51 | - | - | 1,398 | - |
| Divestments | -12,078 | -34 | -50 | - | - | - |
| Issues | - | - | 43 | - | 6 | 3 |
| Settlements | - | - | -20 | - | -442 | -28 |
| Transfer out of Level 3 | -45 | - | - | - | - | - |
| Carrying amount at end of the period | 33,756 | 160 | 3,745 | 46 | 5,935 | 101 |
| Total unrealized gains/losses for the period included in profit/loss for financial instruments held at the end of the period |
||||||
| Changes in value | -8,414 | - | - | - | 1,613 | - |
| Net financial items | - | - | -50 | 14 | -481 | - |
| Total | -8,414 | - | -50 | 14 | 1,132 | - |
| Group 2022 | Field of operation | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| SEK m | Healthcare equipment |
Healthcare services |
Real estate | Osmolality testing |
Gripping and moving solutions |
Total | |||
| Geographical market | |||||||||
| Sweden | 853 | 236 | 285 | 1 | 115 | 1,490 | |||
| Scandinavia, excl. Sweden | 1,385 | 17 | - | 5 | 47 | 1,454 | |||
| Europe, excl. Scandinavia | 11,022 | 144 | - | 221 | 944 | 12,331 | |||
| U.S. | 29,343 | 365 | - | 908 | 671 | 31,287 | |||
| North America, excl. U.S. | 944 | 2 | - | 63 | 123 | 1,132 | |||
| South America | 383 | 0 | - | 12 | 88 | 482 | |||
| Africa | 317 | 2 | - | 4 | 9 | 333 | |||
| Australia | 1,051 | 2 | - | 15 | 16 | 1,083 | |||
| Asia | 1,648 | 4 | - | 130 | 438 | 2,219 | |||
| Total | 46,946 | 772 | 285 | 1,359 | 2,450 | 51,812 | |||
| Category | |||||||||
| Sales of products | 45,020 | 18 | - | 1,126 | 2,421 | 48,585 | |||
| Sales of services | 1,852 | 754 | - | 233 | 30 | 2,868 | |||
| Revenues from leasing | 65 | - | 282 | - | - | 347 | |||
| Other income | 10 | - | 3 | - | - | 12 | |||
| Total | 46,946 | 772 | 285 | 1,359 | 2,450 | 51,812 | |||
| Sales channels | |||||||||
| Through distributors | 26,732 | 12 | - | 588 | 937 | 28,268 | |||
| Directly to customers | 20,214 | 760 | 285 | 771 | 1,514 | 23,544 | |||
| Total | 46,946 | 772 | 285 | 1,359 | 2,450 | 51,812 | |||
| Timing of revenue recognition | |||||||||
| Goods and services transferred | |||||||||
| at a point of time | 46,489 | 530 | - | 1,288 | 2,450 | 50,758 | |||
| Goods and services transferred | |||||||||
| over time | 457 | 242 | 285 | 70 | - | 1,054 | |||
| Total | 46,946 | 772 | 285 | 1,359 | 2,450 | 51,812 |
Group 2021 Field of operation
| Gripping and | |||||||
|---|---|---|---|---|---|---|---|
| Healthcare | Healthcare | Osmolality | moving | ||||
| SEK m | equipment | services | Hotel | Real estate | testing | solutions | Total |
| Geographical market | |||||||
| Sweden | 747 | 359 | 68 | 229 | 1 | 102 | 1,506 |
| Scandinavia, excl. Sweden | 1,182 | 8 | - | - | 4 | 51 | 1,246 |
| Europe, excl. Scandinavia | 10,006 | 53 | - | - | 203 | 721 | 10,982 |
| U.S. | 21,463 | 261 | - | - | 534 | 436 | 22,694 |
| North America, excl. U.S. | 750 | 0 | - | - | 41 | 94 | 885 |
| South America | 281 | - | - | - | 9 | 58 | 347 |
| Africa | 483 | 0 | - | - | 4 | 6 | 492 |
| Australia | 908 | - | - | - | 12 | 11 | 930 |
| Asia | 1,295 | 26 | - | - | 73 | 260 | 1,654 |
| Total | 37,116 | 707 | 68 | 229 | 880 | 1,738 | 40,737 |
| Category | |||||||
| Sales of products | 35,594 | - | - | - | 779 | 1,713 | 38,087 |
| Sales of services | 1,443 | 707 | 68 | - | 101 | 25 | 2,343 |
| Revenues from leasing | 70 | - | - | 224 | - | - | 293 |
| Other income | 9 | - | - | 5 | - | - | 14 |
| Total | 37,116 | 707 | 68 | 229 | 880 | 1,738 | 40,737 |
| Sales channels | |||||||
| Through distributors | 20,813 | - | 41 | - | 432 | 691 | 21,977 |
| Directly to customers | 16,303 | 707 | 27 | 229 | 447 | 1,047 | 18,760 |
| Total | 37,116 | 707 | 68 | 229 | 880 | 1,738 | 40,737 |
| Timing of revenue recognition | |||||||
| Goods and services transferred | |||||||
| at a point of time | 36,734 | 707 | - | - | 856 | 1,738 | 40,035 |
| Goods and services transferred | |||||||
| over time | 382 | - | 68 | 229 | 23 | - | 702 |
| Total | 37,116 | 707 | 68 | 229 | 880 | 1,738 | 40,737 |
In the financial statements issued by Investor, Alternative Performance Measures (APMs) are disclosed, which complete measures that are defined or specified in the applicable financial reporting framework, such as revenue, profit or loss or earnings per share.
APMs are disclosed when they complement performance measures defined by IFRS. The basis for disclosed APMs are that they are used by management to evaluate the financial performance and in so believed to give analysts and other stakeholders valuable information.
Investor AB discloses the definitions of all APMs used on http://www.investorab.com/investors-media/investor-infigures/definitions and on pages 127-128 in the Annual Report 2021. Below reconciliations of significant APMs to the most directly reconcilable line item, subtotal or total presented in the financial statements of the corresponding period are disclosed.
Gross cash or Investor's cash and readily available placements are defined as the sum of cash and cash equivalents, short-term investments and interest-bearing current and long-term receivables. Deductions are made for items related to subsidiaries within Patricia Industries.
| Group 12/31 2022, SEK m |
Consolidated balance sheet |
Deductions related to Patricia Industries |
Investor's gross cash |
Group 12/31 2021, SEK m |
Consolidated balance sheet |
Deductions related to Patricia Industries |
Investor's gross cash |
|---|---|---|---|---|---|---|---|
| Other financial | Other financial | ||||||
| investments | 9,705 | -116 | 9,590 | investments | 14,778 | -236 | 14,542 |
| Cash, bank and short | Cash, bank and short | ||||||
| term investments | 26,304 | -7,361 | 18,943 | term investments | 18,534 | -9,121 | 9,413 |
| Gross cash | 36,009 | -7,476 | 28,533 | Gross cash | 33,311 | -9,357 | 23,955 |
Gross debt is defined as interest-bearing current and long-term liabilities, including pension liabilities, less derivatives with positive value related to the loans. Deductions are made for items related to subsidiaries within Patricia Industries.
| Group 12/31 2022, SEK m |
Consolidated balance sheet |
Deductions related to Patricia Industries |
Investor's gross debt |
Group 12/31 2021, SEK m |
Consolidated balance sheet |
Deductions related to Patricia Industries |
Investor's gross debt |
|---|---|---|---|---|---|---|---|
| Receivables included in net debt |
945 | -148 | 797 | Receivables included in net debt |
1,964 | - | 1,964 |
| Loans | -91,220 | 51,728 | -39,492 | Loans | -87,221 | 46,919 | -40,301 |
| Provision for pensions | -799 | 699 | -101 | Provision for pensions | -1,068 | 959 | -109 |
| Gross debt | -91,074 | 52,278 | -38,796 | Gross debt | -86,324 | 47,878 | -38,446 |
Gross debt less gross cash at Balance Sheet date.
| Group 12/31 2022, SEK m |
Group 12/31 2021, SEK m |
||
|---|---|---|---|
| Investor's gross cash | -28,533 | Investor's gross cash | -23,955 |
| Investor's gross debt | 38,796 | Investor's gross debt | 38,446 |
| Investor's net debt | 10,263 | Investor's net debt | 14,491 |
The net of all assets and liabilities not included in net debt. Total reported assets are based on reported values according to IFRS. Total adjusted assets are adjusted for estimated market values for Patricia Industries' major subsidiaries and partner-owned investments.
| Group 12/31 2022, SEK m |
Consolidated balance sheet |
Deductions related to non controlling interest |
Investor's net asset value |
Group 12/31 2021, SEK m |
Consolidated balance sheet |
Deductions related to non controlling interest |
Investor's net asset value |
|---|---|---|---|---|---|---|---|
| Equity Investor's net debt |
605,653 | -788 | 604,865 10,263 |
Equity Investor's net debt |
683,505 | -891 | 682,614 14,491 |
| Total reported assets |
615,128 | Total reported assets |
697,105 | ||||
| Adjustment for estimated market value Patricia Industries holdings |
68,385 | Adjustment for estimated market value Patricia Industries holdings |
78,348 | ||||
| Total adjusted assets |
683,513 | Total adjusted assets |
775,453 |
Net debt ratio or leverage is defined as Net debt/Net cash as a percentage of total adjusted assets. The target leverange range is 0-10 percent (net debt to total adjusted assets) over a business cycle.
| Group 12/31 2022, SEK m | Net debt ratio | Group 12/31 2021, SEK m | Net debt ratio | ||
|---|---|---|---|---|---|
| Investor's net debt | 10,263 = | 1.5% | Investor's net debt | 14,491 = | 1.9% |
| Total adjusted assets | 683,513 | Total adjusted assets | 775,453 |
Reported net asset value is equal to Investor's net asset value and equity attributable to owners of the Parent Company.
Net asset value based on estimated market values for Patricia Industries' major subsidiaries and partner-owned investments. The estimated market values are mainly based on valuation multiples, typically Enterprise value (EV)/Last 12 months' operating profit, for relevant listed peers and indices. More information about the assessment basis can be found in section Patricia Industries - valuation overview on page 8 and Patricia Industries, overview of estimated market values on page 32. In the table below there are a reconciliation between Reported net asset value and Adjusted net asset value. More details regarding the differences can be found in the table Net asset value overview on page 4.
| Group 12/31 2022, SEK m |
Group 12/31 2021, SEK m |
||
|---|---|---|---|
| Reported net asset value | 604,865 | Reported net asset value | 682,614 |
| Reported value for net assets Patricia Industries |
-70,110 | Reported value for net assets Patricia Industries |
-65,758 |
| Estimated market value Patricia Industries holdings |
138,495 | Estimated market value Patricia Industries holdings |
144,106 |
| Adjusted net asset value | 673,250 | Adjusted net asset value | 760,962 |
Equity attributable to shareholders of the Parent Company in relation to the number of shares outstanding at the Balance Sheet date.
| Group 12/31 2022, SEK m | Net asset value, SEK per share |
Group 12/31 2021, SEK m | Net asset value, SEK per share |
||
|---|---|---|---|---|---|
| Investor's reported net asset value | 604,865 | Investor's reported net asset value | 682,614 | ||
| Number of shares, excluding own shares |
= 3,063,045,776 |
197 | Number of shares, excluding own shares |
= 3,063,457,767 |
223 |
Total assets, including estimated market values for Patricia Industries' major subsidiaries and partner-owned investments, less net debt in relation to the number of shares outstanding at the Balance Sheet date.
| Group 12/31 2022, SEK m | Net asset value, SEK per share |
Group 12/31 2021, SEK m | Net asset value, SEK per share |
||
|---|---|---|---|---|---|
| Investor's adjusted net asset value | 673,250 | Investor's adjusted net asset value | 760,962 | ||
| Number of shares, excluding own shares |
= 3,063,045,776 |
220 | Number of shares, excluding own shares |
= 3,063,457,767 |
248 |
| FY | Q4 | Q3 | Q2 | Q1 | FY | Q4 | Q3 | Q2 | Q1 | FY | Q4 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022 | 2022 | 2022 | 2022 | 2022 | 2021 | 2021 | 2021 | 2021 | 2021 | 2020 | 2020 | |
| Mölnlycke (EUR m) Sales |
1,828 | 474 | 469 | 459 | 426 | 1,686 | 420 | 405 | 417 | 443 | 1,793 | 554 |
| Sales growth, % | 8 | 13 | 16 | 10 | -4 | -6 | -24 | -15 | 16 | 11 | 16 | 38 |
| Organic growth, | 4 | 9 | 9 | 5 | -7 | -6 | -26 | -16 | 18 | 14 | 18 | 41 |
| constant currency, % EBITDA |
476 | 105 | 134 | 125 | 112 | 485 | 106 | 112 | 123 | 146 | 536 | 174 |
| EBITDA, % | 26.1 | 22.2 | 28.6 | 27.2 | 26.4 | 28.8 | 25.1 | 27.5 | 29.4 | 32.9 | 29.9 | 31.4 |
| EBITA2) | 410 | 89 | 118 | 108 | 96 | 421 | 89 | 95 | 107 | 130 | 475 | 159 |
| EBITA, % | 22.4 | 18.7 | 25.1 | 23.6 | 22.6 | 25.0 | 21.2 | 23.4 | 25.6 | 29.4 | 26.5 | 28.8 |
| Operating cash flow | 298 | 78 | 119 | 73 | 28 | 382 | 128 | 91 | 84 | 79 | 470 | 229 |
| Net debt | 1,621 | 1,621 | 1,418 | 1,478 | 1,522 | 1,510 | 1,510 | 1,568 | 1,623 | 1,473 | 1,492 | 1,492 |
| Employees Laborie (USD m) |
8,775 | 8,775 | 8,800 | 8,625 | 8,340 | 8,315 | 8,315 | 8,175 | 8,040 | 7,850 | 7,910 | 7,910 |
| Sales | 339 | 89 | 85 | 87 | 79 | 313 | 84 | 74 | 80 | 76 | 230 | 69 |
| Sales growth, % | 8 | 6 | 15 | 9 | 4 | 36 | 20 | 19 | 85 | 37 | 12 | 23 |
| Organic growth, | 12 | 9 | 20 | 9 | 4 | 21 | 14 | 6 | 67 | 11 | -19 | -14 |
| constant currency, % EBITDA |
97 | 29 | 26 | 23 | 18 | 93 | 22 | 20 | 28 | 23 | 44 | 22 |
| EBITDA, % | 28.6 | 32.7 | 31.3 | 26.8 | 23.1 | 29.9 | 26.4 | 27.7 | 34.5 | 30.9 | 19.1 | 31.2 |
| EBITA2) | 90 | 27 | 25 | 22 | 17 | 83 | 20 | 18 | 25 | 20 | 37 | 19 |
| EBITA, % | 26.7 | 30.6 | 29.5 | 25.0 | 21.0 | 26.6 | 24.2 | 24.4 | 31.3 | 26.7 | 16.0 | 27.5 |
| Operating cash flow | 49 | 14 | 20 | 13 | 2 | 60 | 20 | 16 | 22 | 2 | 21 | 15 |
| Net debt Employees |
454 895 |
454 895 |
461 910 |
475 885 |
455 805 |
424 780 |
424 780 |
366 780 |
396 775 |
400 825 |
403 870 |
403 870 |
| Sarnova (USD m) | ||||||||||||
| Sales | 917 | 245 | 239 | 211 | 222 | 835 | 233 | 230 | 183 | 191 | 725 | 199 |
| Sales growth, % | 10 | 6 | 4 | 15 | 16 | 15 | 17 | 34 | 10 | 1 | 12 | 29 |
| Organic growth, constant currency, % |
2 | 6 | -5 | 6 | 3 | 0 | 0 | 14 | -3 | -10 | 9 | 19 |
| EBITDA | 135 | 41 | 36 | 28 | 30 | 104 | 30 | 24 | 23 | 27 | 78 | 20 |
| EBITDA, % | 14.8 | 16.8 | 14.9 | 13.4 | 13.7 | 12.5 | 13.1 | 10.3 | 12.6 | 14.2 | 10.8 | 9.9 |
| EBITA2) | 118 | 37 | 31 | 24 | 26 | 91 | 25 | 21 | 20 | 24 | 69 | 17 |
| EBITA, % | 12.9 | 15.0 | 13.1 | 11.5 | 11.8 | 10.9 | 10.9 | 9.1 | 11.0 | 12.7 | 9.5 | 8.5 |
| Operating cash flow | 102 | 29 | 15 | 20 | 38 | 77 | 21 | 9 | 24 | 23 | 49 | -6 |
| Net debt Employees |
526 1,435 |
526 1,435 |
541 1,355 |
538 1,360 |
538 1,375 |
569 1,370 |
569 1,370 |
578 1,370 |
496 1,240 |
509 1,215 |
525 1,195 |
525 1,195 |
| Permobil (SEK m) | ||||||||||||
| Sales | 5,248 | 1,545 | 1,410 | 1,177 | 1,116 | 4,062 | 1,119 | 1,054 | 981 | 908 | 3,944 | 1,021 |
| Sales growth, % | 29 | 38 | 34 | 20 | 23 | 3 | 10 | 12 | 8 | -15 | -11 | -16 |
| Organic growth, constant currency, % |
9 | 17 | 12 | 0 | 6 | 6 | 6 | 11 | 18 | -7 | -9 | -10 |
| EBITDA | 1,071 | 389 | 317 | 187 | 177 | 782 | 192 | 211 | 187 | 192 | 826 | 225 |
| EBITDA, % | 20.4 | 25.1 | 22.5 | 15.9 | 15.9 | 19.2 | 17.2 | 20.1 | 19.0 | 21.1 | 20.9 | 22.0 |
| EBITA2) | 880 | 335 | 266 | 145 | 133 | 612 | 149 | 168 | 147 | 148 | 641 | 178 |
| EBITA, % | 16.8 | 21.7 | 18.9 | 12.3 | 12.0 | 15.1 | 13.3 | 16.0 | 15.0 | 16.3 | 16.3 | 17.4 |
| Operating cash flow Net debt |
435 3,330 |
252 3,330 |
182 3,752 |
13 3,568 |
-13 3,388 |
214 3,166 |
37 3,166 |
90 3,026 |
-12 2,959 |
98 2,671 |
835 2,559 |
197 2,559 |
| Employees | 1,805 | 1,805 | 1,780 | 1,755 | 1,755 | 1,660 | 1,660 | 1,645 | 1,630 | 1,540 | 1,570 | 1,570 |
| Advanced Instruments (USD m) | ||||||||||||
| Sales | 134 | 35 | 35 | 33 | 31 | 103 | 31 | 26 | 24 | 22 | 77 | 22 |
| Sales growth, % | 31 | 13 | 33 | 41 | 44 | 34 | 45 | 33 | 49 | 11 | 9 | 16 |
| Organic growth, constant currency, % |
7 | -5 | 3 | 16 | 20 | 24 | 18 | 26 | 47 | 11 | 9 | 16 |
| EBITDA | 45 | 11 | 12 | 8 | 14 | 38 | 12 | 3 | 12 | 11 | 37 | 10 |
| EBITDA, % | 33.6 | 32.1 | 35.9 | 22.7 | 44.3 | 37.1 | 37.1 | 13.3 | 50.9 | 50.4 | 47.7 | 48.5 |
| EBITA2) | 43 | 11 | 12 | 7 | 13 | 37 | 11 | 3 | 12 | 11 | 35 | 10 |
| EBITA, % Operating cash flow |
32.1 35 |
30.6 7 |
34.3 16 |
21.3 8 |
42.8 5 |
35.7 32 |
35.8 10 |
11.9 7 |
49.5 9 |
48.9 6 |
46.0 34 |
47.2 12 |
| Net debt | 206 | 206 | 206 | 208 | 192 | 195 | 195 | 203 | 142 | 149 | 152 | 152 |
| Employees | 370 | 370 | 370 | 350 | 225 | 225 | 225 | 225 | 145 | 130 | 130 | 130 |
| Piab (SEK m) | ||||||||||||
| Sales | 2,450 | 661 | 620 | 619 | 551 | 1,738 | 472 | 438 | 422 | 406 | 1,526 | 435 |
| Sales growth, % Organic growth, |
41 | 40 | 42 | 47 | 36 | 14 | 8 | 25 | 23 | 2 | 20 | 36 |
| constant currency, % | 11 | 7 | 6 | 17 | 17 | 18 | 8 | 26 | 33 | 9 | -4 | 12 |
| EBITDA | 619 | 122 | 163 | 173 | 161 | 485 | 109 | 130 | 126 | 121 | 420 | 124 |
| EBITDA, % | 25.2 | 18.4 | 26.2 | 27.9 | 29.3 | 27.9 | 23.1 | 29.6 | 29.8 | 29.8 | 27.5 | 28.5 |
| EBITA2) EBITA, % |
530 21.6 |
97 14.7 |
139 22.4 |
152 24.5 |
142 25.9 |
409 23.5 |
81 17.2 |
113 25.9 |
110 26.0 |
105 25.9 |
359 23.5 |
107 24.6 |
| Operating cash flow | 411 | 113 | 138 | 102 | 58 | 376 | 79 | 106 | 104 | 87 | 364 | 85 |
| Net debt | 2,431 | 2,431 | 2,591 | 2,423 | 1,986 | 1,767 | 1,767 | 1,505 | 1,548 | 1,592 | 1,574 | 1,574 |
| Employees | 1,030 | 1,030 | 1,020 | 995 | 875 | 695 | 695 | 680 | 660 | 650 | 625 | 625 |
| FY | Q4 | Q3 | Q2 | Q1 | FY | Q4 | Q3 | Q2 | Q1 | FY | Q4 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022 | 2022 | 2022 | 2022 | 2022 | 2021 | 2021 | 2021 | 2021 | 2021 | 2020 | 2020 | |
| BraunAbility (USD m) | ||||||||||||
| Sales | 929 | 242 | 252 | 211 | 224 | 692 | 184 | 192 | 171 | 146 | 567 | 150 |
| Sales growth, % | 34 | 32 | 31 | 24 | 53 | 22 | 22 | 26 | 86 | -15 | -23 | -21 |
| Organic growth, constant currency, % |
28 | 25 | 28 | 19 | 43 | 17 | 14 | 17 | 81 | -16 | -24 | -22 |
| EBITDA | 86 | 24 | 23 | 17 | 22 | 52 | 13 | 17 | 12 | 10 | 44 | 12 |
| EBITDA, % | 9.3 | 9.9 | 9.3 | 8.1 | 9.8 | 7.5 | 7.2 | 9.0 | 7.1 | 6.6 | 7.7 | 7.9 |
| EBITA2) | 67 | 19 | 19 | 13 | 17 | 35 | 9 | 13 | 8 | 6 | 29 | 8 |
| EBITA, % | 7.2 | 7.7 | 7.5 | 5.9 | 7.7 | 5.1 | 4.6 | 6.6 | 4.9 | 4.1 | 5.1 | 5.2 |
| Operating cash flow | 46 | 14 | 19 | 3 | 9 | 38 | 8 | 23 | 6 | 2 | 20 | 30 |
| Net debt | 284 | 284 | 288 | 302 | 302 | 300 | 300 | 307 | 326 | 190 | 189 | 189 |
| Employees | 1,945 | 1,945 | 1,995 | 1,890 | 1,850 | 1,825 | 1,825 | 1,825 | 1,760 | 1,495 | 1,555 | 1,555 |
| Vectura (SEK m) | ||||||||||||
| Sales | 302 | 78 | 74 | 75 | 74 | 279 | 71 | 61 | 66 | 81 | 298 | 90 |
| Sales growth, % | 8 | 9 | 23 | 14 | -8 | -6 | -20 | -21 | -3 | 29 | 9 | 24 |
| EBITDA | 178 | 42 | 45 | 47 | 44 | 172 | 42 | 40 | 41 | 48 | 184 | 60 |
| EBITDA, % | 58.9 | 53.9 | 60.4 | 62.0 | 59.6 | 61.5 | 59.2 | 66.2 | 62.1 | 59.6 | 61.9 | 67.4 |
| EBITA adjusted2) | 50 | 10 | 13 | 15 | 13 | 45 | 7 | 13 | 13 | 12 | 34 | 2 |
| EBITA, % | 16.7 | 12.5 | 17.0 | 20.1 | 17.3 | 16.0 | 9.5 | 21.7 | 19.8 | 14.4 | 11.4 | 2.1 |
| Operating cash flow | -614 | -160 | -76 | -252 | -126 | -355 | -97 | -52 | -160 | -46 | -1,450 | -574 |
| Net debt | 5,223 | 5,223 | 4,984 | 4,376 | 4,343 | 3,963 | 3,963 | 3,453 | 2,537 | 4,361 | 4,302 | 4,302 |
| Real estate, market value |
9,650 | 9,650 | 8,388 | 9,182 | ||||||||
| Employees | 49 | 49 | 44 | 41 | 38 | 33 | 33 | 31 | 31 | 34 | 31 | 31 |
| Atlas Antibodies (SEK m) | ||||||||||||
| Sales | 398 | 98 | 100 | 104 | 95 | 324 | 81 | 86 | 81 | 76 | 247 | 66 |
| Sales growth, % | 23 | 21 | 16 | 29 | 26 | 31 | 23 | 38 | 43 | 23 | 13 | 24 |
| Organic growth, | 14 | 9 | 7 | 21 | 20 | 34 | 19 | 39 | 47 | 32 | 15 | 30 |
| constant currency, % EBITDA |
187 | 42 | 52 | 48 | 45 | 162 | 42 | 45 | 36 | 40 | 124 | 33 |
| EBITDA, % | 47.0 | 42.8 | 52.3 | 45.7 | 47.4 | 50.1 | 51.4 | 52.3 | 43.9 | 52.7 | 50.2 | 50.5 |
| EBITA2) | 165 | 36 | 46 | 42 | 40 | 143 | 37 | 40 | 31 | 36 | 107 | 29 |
| EBITA, % | 41.4 | 37.0 | 46.4 | 40.4 | 41.9 | 44.2 | 45.0 | 46.5 | 38.1 | 47.0 | 43.3 | 44.1 |
| Operating cash flow | 94 | 17 | 45 | 18 | 14 | 115 | 24 | 56 | 13 | 23 | 78 | 33 |
| Net debt | 342 | 342 | 352 | 391 | 403 | 406 | 406 | 429 | 22 | 24 | -117 | -117 |
| Employees | 130 | 130 | 120 | 120 | 120 | 115 | 115 | 110 | 115 | 110 | 95 | 95 |
| Three Scandinavia | ||||||||||||
| Sales, SEK m | 11,834 | 3,283 | 3,025 | 2,798 | 2,728 | 10,750 | 2,925 | 2,696 | 2,543 | 2,586 | 10,668 | 2,873 |
| Sweden, SEK m | 7,668 | 2,160 | 1,942 | 1,817 | 1,749 | 6,946 | 1,929 | 1,740 | 1,617 | 1,659 | 6,818 | 1,879 |
| Denmark, DKK m | 2,904 | 756 | 755 | 700 | 694 | 2,787 | 730 | 697 | 676 | 683 | 2,740 | 723 |
| EBITDA, SEK m | 3,729 | 973 | 948 | 917 | 891 | 3,535 | 931 | 892 | 849 | 863 | 3,934 | 923 |
| Sweden, SEK m | 2,732 | 706 | 695 | 675 | 656 | 2,564 | 636 | 662 | 625 | 641 | 2,725 | 616 |
| Denmark, DKK m | 694 | 180 | 176 | 172 | 167 | 711 | 216 | 168 | 164 | 164 | 861 | 224 |
| EBITDA, % | 31.5 | 29.7 | 31.3 | 32.8 | 32.7 | 32.9 | 31.8 | 33.1 | 33.4 | 33.4 | 36.9 | 32.1 |
| Sweden | 35.6 | 32.7 | 35.8 | 37.2 | 37.5 | 36.9 | 33.0 | 38.1 | 38.6 | 38.6 | 40.0 | 32.8 |
| Denmark | 23.9 | 23.8 | 23.3 | 24.6 | 24.0 | 25.5 | 29.6 | 24.1 | 24.2 | 24.0 | 31.4 | 30.9 |
| Net debt, SEK m | 7,294 | 7,294 | 6,969 | 6,731 | 6,406 | 6,498 | 6,498 | 5,940 | 6,070 | 6,173 | 6,341 | 6,341 |
| Employees | 1,790 | 1,790 | 1,765 | 1,715 | 1,735 | 1,735 | 1,735 | 1,685 | 1,775 | 1,740 | 1,775 | 1,775 |
1) For information regarding Alternative Performance Measures in the table, see page 18. Definitions can be found on Investor's website.
2) EBITA is defined as operating profit before acquisition-related amortizations.
| Valuation methodology | |
|---|---|
| Listed Companies | Share price (bid) for the class of shares held by Investor, with the exception of Saab, Electrolux and Electrolux Professional for which the most actively traded share class is used. Ownership calculated in accordance with the disclosure of regulations of Sweden's Financial Instruments Trading Act (LHF). ABB, Accelleron, AstraZeneca, Nasdaq and Wärtsilä in accordance with Swiss, British, U.S. and Finnish regulations. Includes market value of derivatives related to investments if applicable. |
| Patricia Industries | |
| Subsidiaries | Reported value based on the acquisition method. As supplementary information, subsidiaries are also presented at estimated market values, mainly based on valuation multiples for relevant listed peers and indices. Other methodologies may also be used, for example relating to real estate assets. New investments valued at invested amount during the first 18 months following the acquisition. |
| Partner-owned investments | Reported value based on the equity method. As supplementary information, partner-owned investments are also presented at estimated market values, mainly based on valuation multiples for relevant listed peers and indices. |
| Financial Investments | Unlisted holdings at multiple or third-party valuation, listed shares at share price (bid). |
| Investments in EQT | Unlisted holdings at multiple or third-party valuation, listed shares at share price (bid). |
| Supplementary information | In addition to reported values, which are in accordance with IFRS, Investor provides estimated market values for the wholly-owned subsidiaries and partner-owned investments within Patricia Industries in order to facilitate the evaluation of Investor's net asset value. This supplementary, non-GAAP information also increases the consistency between the valuation of Listed Companies and our major wholly-owned subsidiaries and partner-owned Three Scandinavia. |
|---|---|
| Estimated market values | While the estimated market values might not necessarily reflect our view of the intrinsic values, they reflect how the stock market values similar companies. |
| Methodology | The estimated market values are mainly based on valuation multiples (median), typically Enterprise value (EV)/Last 12 months' operating profit, for relevant listed peers and indices. We define EV as quarterly volume-weighted average share price (VWAP) plus closing date net debt. While we focus on EBITA when evaluating the performance of our companies, for valuation purposes, EBITDA multiples are more commonly available, and therefore often used. From the estimated EV, net debt is deducted, and the remaining equity value is multiplied with Patricia Industries' share of capital. |
| Adjustments | Operating profit is adjusted to reflect, for example, pro forma effects of completed add-on acquisitions and certain non-recurring items. An item is only viewed as non-recurring if it exceeds a certain amount set for each company, is unlikely to affect the company again, and does not result in any future benefit or cost. Acquisitions made less than 18 months ago are valued at cost. |
Investor, founded by the Wallenberg family in 1916, is an engaged owner of high-quality, global companies. We have a long-term investment perspective. Through board representation, as well as industrial experience, our network and financial strength, we work continuously to support our companies to remain or become best-in-class. Our holdings include, among others, ABB, Atlas Copco, Ericsson, Mölnlycke and SEB.
We create value for people and society by building strong and sustainable businesses.
Our ultimate target is to generate an attractive total return. Our long-term return requirement is the risk free interest rate plus an equity risk premium, in total 8-9 percent annually.
We own high-quality companies and are an engaged owner, supporting our companies to achieve profitable growth. We strive to allocate our capital wisely.
Our goal is to pay a steadily rising dividend. Our dividend policy is supported by cash flow from all three business areas: Listed Companies, Patricia Industries and Investments in EQT.
We firmly believe that sustainability integrated in the business model is a prerequisite for creating long-term value. Our three focus areas with specific targets are Business Ethics & Governance, Climate & Resource Efficiency and Diversity & Inclusion.

Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.